Emäskatalysoitu aryylialdehydien ja valiinista johdettujen boroksatsolidonien kondensaatio by Raunio, Jenna
  
 
 
 
 
 
 
 
 
 
 
JENNA RAUNIO 
BASE-CATALYSED CONDENSATION OF ARYL ALDEHYDES 
AND VALINE-DERIVED BOROXAZOLIDONES 
 
Master of Science Thesis 
 
 
 
 
 
Examiners: 
Professor Robert Franzén 
Academy Research Fellow Nuno R. Candeias 
Examiners and topic approved by the Faculty 
Council of the Faculty of Engineering Sciences 
on 8th of June 2016 
 
 
II 
 
ABSTRACT 
RAUNIO, JENNA: Base-catalysed condensation of aryl aldehydes and valine-
derived boroxazolidones 
 
Tampere University of Technology 
Master of Science Thesis, 50 pages, 66 Appendix pages 
October 2016 
Master’s Degree Programme in Science and Engineering 
Major: Materials Chemistry 
Examiners: Professor Robert Franzén, Academy Research Fellow Nuno R. 
Candeias 
 
Keywords: imine condensation, organoboron compounds, N-B bond, boroxazol-
idones, aryl aldehydes, base catalysis 
Imines are an important group of compounds for many chemical reactions in organic 
chemistry, mostly as electrophiles. In nature, imines are important for the transamina-
tion reaction. N-B bonds are interesting because they can be thought of as an analogy to 
a C-C bond. However, unlike a C-C bond, the N-B bond is polarized. Imines and N-B 
bond-containing compounds both have similar potentials as pharmaceuticals. Both of 
these groups can have antibacterial, antifungal and anticancer effects. The N-B bond 
focused on in this thesis is formed when an amino acid reacts with a boron compound to 
form a hetero ring structure known as a boroxazolidone. 
In this master’s thesis, the imine condensation between aldehydes and boroxazolidones, 
and the N-B bond were studied. Boroxazolidones with differing substituents at the bo-
ron were prepared from the corresponding triethylammonium tetra-arylborates (TEAT-
ABs) and (L)-valine. These were then reacted with different aryl aldehydes in the pres-
ence of a base as a catalyst to afford the corresponding imines. The general procedures 
for preparing the TEATABs, the boroxazolidones and imines had already been estab-
lished in prior projects in the laboratory.  
Two Lewis bases, 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD) and sodium methoxide 
(NaOMe), were found to produce the most simple ketimine and aldimine respectively in 
good yields and without side products. However, the aldimine is very labile and reverts 
easily to its starting materials.  When testing other aldehydes with TBD, it was found 
that the yields range from 63 to 0 %, in this general order depending on the aldehyde’s 
substituents: halogen-substituted > electron withdrawing but non-halogen-substituted > 
electron donating. 4-Methoxybenzaldehyde was an exception to this because it pro-
duced a decent yield. Five different boroxazolidones were prepared from the corre-
sponding TEATABs. The effect of the boroxazolidones’ substituents at boron had a 
lesser effect on the imine yield than the aldehydes’ substituents. Difluoro- and methyl-
substituted boroxazolidones produced good yields but the 4-methoxy-substituted borox-
azolidone produced a much lower yield. 
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Imiinit ovat tärkeitä orgaanisessa kemiassa – lähinnä elektrofiileina. Luonnossa imiinit 
ovat tärkeitä transaminaatio-reaktion kannalta. Typpi-boori-sidokset ovat kiinnostavia, 
sillä ne ovat analogisia hiili-hiili-sidosten kanssa. Mutta toisin kuin hiili-hiili-sidokset, 
typpi-boori-sidokset ovat polarisoituneita. Sekä imiineillä että typpi-boori-sidoksen 
sisältävillä yhdisteillä on ominaisuuksia, jotka ovat kiinnostavia lääketieteessä. Niillä 
voi olla bakteereita, sieniä tai syöpää torjuvia vaikutuksia. Tässä opinnäytetyössä 
keskitytään typpi-boori-sidokseen, joka syntyy aminohapon reagoidessa booriyhdisteen 
kanssa muodostaen boroksatsolidonina tunnetun heterorenkaan.  
Tässä diplomityössä tutkittiin aldehydien ja boroksatsolidonien välistä 
imiinikondensaatiota sekä typpi-boori-sidosta. Boroksatsolidoneja, joissa boori oli 
vaihtelevasti substituoitu, valmistettiin niitä vastaavista trieyyliammonium tetra-
aryyliboraateista (TEATAB:eista) ja L-valiinista. Näistä boroksatsolidoneista ja 
erinäisistä aryylialdehydeistä valmistettiin vastaavia imiinejä. Imiinien muodostukseen 
vaaditaan katalyytiksi emäs. Trietyyliammonium tetra-aryyliboraattien, 
boroksatsolidonien ja imiinien valmistukseen tarvittavat reaktiot oli kehitetty jo 
aiemmissa projekteissa. 
Kaksi eri Lewis-emästä – 1,5,7-triatsabisyklo[4.4.0]dek-5-eeni (TBD) ja 
natriumetoksidi (NaOMe) – tuottivat yksinkertaisimman ketimiinin ja aldimiinin 
hyvällä saannolla ilman sivutuotteita. Aldimiini on kuitenkin hyvin epävakaa ja 
palautuu helposti lähtöaineikseen. Useiden aldehydien testaus TBD:n katalysoimana 
tuotti saantoja 63 ja 0 %:n väliltä. Saanto riippui aldehydien substituenteista seuraavasti: 
halogeeni-substituoidut > elektroneja puoleensa vetävät ryhmät, jotka eivät sisällä 
halogeeneja > elektroneja työntävät ryhmät. 4-Metoksibentsaldehydi oli poikkeus tähän 
sääntöön, sillä sen reaktio tuotti tyydyttävän saannon. Viisi erilaista boroksatsolidonia 
valmistettiin vastaavista TEATAB:eista. Boroksatsolidonien boorin substituenttien 
vaikutus imiinin muodostumiseen oli pienempi kuin aldehydien substituenttien 
vaikutus. Difluori- ja metyyli-substituoidut boroksatsolidonit tuottivat suunnilleen yhtä 
hyvän saannon, mutta 4-metoksi-substituoitu boroksatsolidoni tuotti selvästi 
alhaisemman saannon. 
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11. BACKGROUND
This thesis’ foundation is in the doctoral thesis of Noora Kuuloja [1] and the master’s 
thesis of Jenna Mannoja [2]. Kuuloja developed a method to produce N-B bond-
containing ring structures called boroxazolidones from triethylammonium tetra-
arylborates and (L)-valine [3]. Later studies found that these boroxazolidones could 
react with benzaldehyde to give two isomeric forms of imines, a ketimine and an 
aldimine. 
Mannoja studied this imine formation reaction and found that by using different bases 
as catalysts, it was possible to form either the ketimine, aldimine or a mixture of them. 
Mannoja improved the reaction by finding the right equivalents of reagents, a good 
solvent and the right temperature. She found that unlike typically in imine condensation 
reactions, a Lewis acid does not work with this reaction and that water removal is not 
necessary [2].
The aim of this thesis is to further study this imine formation reaction and the N-B bond 
of boroxazolidones. This is done by first testing other bases in an attempt to further 
improve the reaction between benzaldehyde and the simplest boroxazolidone, which has 
two unsubstituted phenyl groups at the boron. This screening could give more 
information about what controls the formation of either the ketimine or the aldimine. 
After this, different aryl aldehydes are tested with the simplest boroxazolidone, and 
finally, different boroxazolidones are tested with benzaldehyde.
Chapter 2 gives background information about boron compounds, N-B bonds, 
boroxazolidones, tetra-arylborates and imines. Chapter 3 contains the results and 
discussion from the aforementioned reactions. Chapter 4 describes the procedures used 
in detail.
22. INTRODUCTION
2.1 General boron information
Boron is the fifth element and belongs to group 13 or IIIA in the periodic table. It is a 
metalloid and has a very high melting point of ~3400 K [4]. Boron has the electron 
configuration of 1s22s22p1. It is thought to be electron deficient because it has only three 
valence electrons and cannot easily form an octet by bonding. Boron has two stable 
isotopes, 10B and 11B with a ratio of about 1:4 in nature. Unlike aluminum, which 
belongs to the same group, boron does not form a trivalent cation. Because of its small 
size and high ionic potential, boron forms only covalent bonds, unlike aluminum. In 
nature, boron exists as mostly bound to oxygen as borates or boric acid and, much more 
rarely, to fluorine as BF4- [4]. Boron typically has a coordination number of three or 
four [5]. Coordination numbers of five and six are observed only in laboratory 
conditions [4]. Boron can adopt trigonal and tetrahedral geometries, which makes it an 
important element and boron chemistry a large field [6]. Boron is one of the vital 
inorganic elements needed by living organisms. Other such inorganic elements are, for 
example, phosphorus, manganese, molybdenum, copper and zinc. [7]
Boron is important for many purposes such as in glassware, fiberglass, laundry 
bleaches, fire retardants, fertilizers, metallurgy fluxes, insecticides, herbicides and 
reagents for chemical synthesis. The economically useful boron mineral deposits are 
rare, and in these, the boron is bound to oxygen. Boron is an essential micronutrient for 
plants but the exact mechanisms of boron in plants are unknown (year 1994). In higher 
amounts, it can be used to preserve wood and to control weeds or insects. [6] Boron can 
also be used for nuclear shielding [5] and in boron neutron capture therapy (BNCT) 
due to 10B’s large neutron capture radius. This makes boron compounds generally 
interesting for cancer treatments. [8]
Table 1: End use of boron in the U.S in the year 2000 [5]
Usage %
Glass products 75.7
Sold to distributor / end use unknown 8.6
Soaps and detergents 6.5
Agriculture 3.9
Fire retardants 3.6
Miscellaneous 1.5
Metallurgy 0.1
Nuclear applications 0.1
3For plants, boron plays a role in their metabolism, sugar translocation, pollen 
germination, hormone action, growth, nucleic acid synthesis and membrane function. 
Boron deficient plants suffer reduction of growth and finally death. Toxic amounts of 
boron result in leaf loss and loss of photosynthetic capacity. Plants usually tolerate 
between 0.3 to 4 mg of boron per liter in irrigation waters. In animals, boron has an 
effect on the maturation of growth plates in long bones (in chicks) and on the adsorption 
of calcium, magnesium and phosphorus (in mice). The no-observed-adverse-effect level 
(NOAEL) of boron in rats has been determined to be 9.6 mg/kg body weight/day. [5]
Any specific biochemical function for boron has not been found in humans. Regardless 
of this, it is still known that boron is needed, and it affects such things as metabolism, 
utilization of calcium, brain function, psychomotor response and the response to 
estrogen ingestion in menopausal women. The U.S. Environmental Protection Agency 
estimates the safe limit of boron in drinking water to be 0.6 mg of boron per liter. 
Raisins and peanuts contain a high amount of boron: over 1 mg of boron per 100 grams 
of food. Based on the previous NOAEL value, it has been calculated that a 60 kg person 
can acceptably consume 18 mg of boron per day. An average person consumes about 1 
mg of boron per day. [5]
Precipitation, inorganic and organic sorption, ion exchange, membrane filtration and 
phytoremediation (use of plants to absorb boron) can be used to remove boron from 
water but none of these methods is cheap and effective at the same time. This is an 
important area if one wants to use seawater for drinking and irrigation as fresh water 
becomes scarcer. [5] Seawaters’ boron comes mainly from rivers due to continental 
weathering and less so from the hydrothermal activities in the bottom of the seas. Boron 
is removed from the seas by inorganic processes such as adsorption to clay minerals. [7] 
When removing boron from water by membrane filtration, the pH-value is important 
because the charged species (scheme 1) can be better rejected by the membrane [9].
Boric acid B(OH)3 is one of the forms of boron found in nature and the most common 
form of boron in water [5]. Depending on the source, boric acid is presented as a 
monobasic Lewis acid (LA) (eq 1) [4; 5] or as a tribasic Brønsted acid (eq 2 – 4) [9]. 
H3BO3 + H2O⇌H + + H4BO ‒4 pKa 9.10 - 9.24 (eq 1)H3BO3⇌H + + H2BO ‒3 pKa 9.14 (eq 2)H2BO ‒3 ⇌H + + HBO2 ‒3 pKa 12.74 (eq 3)HBO2 ‒3 ⇌H + + BO3 ‒3 pKa 13.8 (eq 4)
Scheme 1: Reactions of boric acid in water
Boron nomenclature can be confusing. Picture 1 contains some boron compounds with 
their names. These names can change depending on the source, and a complete IUPAC 
system has not been developed yet [10]. Even picture 1 is inconsistent regarding the 
terms boronate and borate because two sources had assigned these names to different 
4compounds [10; 11]. The compounds are grouped based on whether the compounds 
have only B-R bonds, are acids, are esters, have tetravalent borons with B-O bonds or 
do not belong to these categories but are still mentioned (boronamide).
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Picture 1: Some boron compounds [10], [11], [12]
Boric acid reacts with alcohols to give esters (Scheme 2). Typically, the equilibrium is 
on the left in aqueous solutions. In some cases, the equilibrium can be moved towards 
the products by removing water by, for example, adding an azeotrope-forming 
compound like toluene and removing the azeotrope by distillation [4].B(OH)3 + 3ROH⇌B(OR)3 + 3H2O
Scheme 2: Reaction of boric acid with an alcohol
Some sugars can form ester-complexes with boric acid by reacting with its hydroxyl 
groups. Some antibiotics contain a tetrahedral boron atom in the middle of their 
structures. [6] Boric acid can react with cis-diols to form boro-spiranes [13].
B
OH
OHOH
+
OH R
OH R
R
RO
O
B-
O
O
R
R
2
6 18 19
- 3 H2O
Scheme 3: Formation of boro-spirane 19 from boric acid 6 and a cis-diol 18
5Boro-spirane-formation and -dissociation might be important for the conversion of 
sugars to starch and cellulose in plants. [13] The stability of this complex is dependent 
on how well the orientation of the diol’s hydroxyl groups matches with the tetrahedral 
coordination of the boron. Polysaccharide/borate complexes have been isolated from 
radish roots. In this case, the boron seems to be a part of the cell wall structure rather 
than a part of the metabolism of the plant. Borate/diol complexes might work as 
crosslinkers between polysaccharide chains in radish root tissue. In peas, B-deficiency 
causes cell walls to become thinner and finally results in cell breakage. However, it is 
not certain that cell wall structures are the reason for the essentiality of boron in plants. 
[4]
The borane BH3 is not stable on its own, but it forms a diborane B2H6 structure with 
itself to become more stable. [13] This is a major difference when compared to the 
analogous carbon compound, methane.  
B
H
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B
H
H
H
H
20
Picture 2: Structure of diborane 20 [13]
The boron in diborane still has a tetrahedral geometry but it can be thought to be 
pentavalent. These bonds involved in the pentavalent complex are called three-center, 
two-electron bonds [4]. Diborane can decompose and form more complex borane 
structures with the trend being that the more stable compounds have increasing boron to 
hydrogen atom ratios. The geometrical configuration of the more stable BxHy 
polyboranes or boron dihydrides resemble that of a sphere, where the borons are on the 
sphere’s surface and the hydrogens are aligned outward. These boron hydrides can be 
thought to still be electron deficient, and they can react with electron donating 
substances like sodium and ammonia. This can form a complex, such as trimethylamine 
borane [(CH3)3NBH3], which enables the boron to have an electron-octet without the 
three-center bonding seen in diborane. Generally, the stronger the base, the more stable 
the resulting complex will be. The more stable polyboranes require stronger bases to 
form these complexes. [13] Ammonia borane (NH3BH3) and similar compounds 
(NHxBHx, x=4, 3, 2 or 1) are being investigated as possible hydrogen storage molecules. 
These kinds of compounds have much higher boiling points than the corresponding 
hydrocarbons and are solids at room temperature. [14] 
2.2 The N-B bond 
The nitrogen-boron bond is an important research area because such compounds can 
have insecticidal, antineoplastic (prevents, inhibits or halts the development of a tumor), 
herbicidal, fungicidal and antibacterial effects. N-B bond -containing chemicals can also 
6work as surfactants where the N-B bond part works as the hydrophilic end [15]. An N-B 
bond can be thought of as an analogy for a C-C bond because they both have a 
tetrahedral character. The N-B bond’s polarity causes the molecules to have higher 
melting and boiling points than the analogous compounds with a C-C bond. [13]
The basis for the bond’s formation is nitrogen’s ability to donate its electron pair to the 
electron deficient boron [16]. This covalent bond is sometimes called a dative bond or a 
coordinative bond, and it can be marked with an arrow (N→B) to show that the 
nitrogen is donating the electrons to the boron. IUPAC defines dative bond as an 
obsolete term because “The origin of the bonding electrons has by itself no bearing on 
the character of the bond formed” [17]. However, on another page they write, “In spite 
of the analogy of dative bonds with covalent bonds, in that both types imply sharing a 
common electron pair between two vicinal atoms, the former are distinguished by their 
significant polarity, lesser strength, and greater length.” [18] Some sources make a 
differentiation between a dative N→B bond (ammonia borane, 130 kJ/mol bond energy) 
and a covalent N-B bond (solid boron nitride, 367 kJ/mol bond energy) [8]. The term 
dative bond or the arrow will not be further used in this thesis.
The following four paragraphs are based on papers studying 2-aminoethylborinates 21. 
Unlike the 1,3λ4,2λ4,-oxazaborolidin-5-ones studied in this thesis and discussed in the 
next subchapter, compound 21 does not have a carbonyl in its ring.
R
R
RR
O
B-
N+ 21
Picture 3: Structure of 2-aminoethylborinate 21 [8]
The N-B bond of a molecule is usually the primary target of nucleophilic reagents like 
water and other polar solvents, which can break the bond via hydrolysis [8]. The 
strength of the N-B bond depends on the Lewis basicity of the nitrogen and Lewis 
acidity of the boron. By adding electron donating groups (EDG) to the nitrogen and 
electron withdrawing groups (EWG) to the boron, the strength of the N-B bond should 
increase. Steric effects of the substituents also have to be taken into account. [19] In a 
five-membered ring containing an N-B-O system, the substituents of the two carbons 
also have an effect on the N-B bond. If the carbons’ substituents have a steric hindrance 
against each other, the N-B bond will weaken. [20]
The following three paragraphs are based on purely theoretical ab initio calculations 
about the N-B-O system of 2-aminoethylborinates with the HF/6-31G** model. Six 
model molecules were studied with differing amounts of hydrogens or methyl groups at 
the boron and nitrogen. The electronegativities of boron, nitrogen, hydrogen and methyl 
are 3.88, 7.62, 7.18 and 7.45, respectively. Hydrogen has a higher electronegativity than 
7boron but lower than nitrogen. This causes the hydrogen to be positively charged when 
bound to nitrogen and negatively charged when bound to boron. This would explain 
why compounds like ammonia borane (NH3BH3) have a much higher boiling point than 
the corresponding hydrocarbon, ethane, because the hydrogen(s) at the boron and 
nitrogen can form hydrogen bonds between molecules [14]. Methyl is more 
electronegative than either the boron or nitrogen, so it is always negatively charged at 
both N and B. These charge clouds of different substituents can weaken or strengthen 
the N-B bond as seen in picture 4. [8]
Another term closely related to electronegativity is electrostatic charge, which is lower 
for nitrogen than for boron.  Replacing the hydrogen with methyl will increase the 
electrostatic charge of nitrogen because the methyl is more electronegative than 
hydrogen. This also reduces the electrostatic charge difference between boron and 
nitrogen. If hydrogen is replaced with methyl at the boron, the boron’s electrostatic 
charge also increases. However, boron has a higher electrostatic charge than nitrogen 
regardless of the N having a hydrogen or methyl substituent, so this causes the 
electrostatic charge difference between B and N to increase. This electrostatic charge 
difference is called polarization across the bond. This effect is not the same as Lewis 
acidity or basicity because it does not consider the mesomeric effect. The authors found 
an inverse relationship between the polarization across the N-B bond and the bond 
length and thus bond strength. This is in agreement with the previously made statements 
about making the nitrogen more Lewis basic by adding an electron-donating group like 
methyl and thus causing the N-B bond to be stronger. The authors suggest that some 
more electronegative groups than methyl could be used to further reduce the bond 
polarization and strengthen the N-B bond but the substituent cannot be too 
electronegative as not to reduce the Lewis basicity of the nitrogen too much. However, 
such calculations were not reported. [8]
Picture 4: An illustration of the substituents’ electrostatic cloud interactions in an N-B-
O system [8]
In an N-B-O system, the substituents of the boron can also interact with the lone pairs of 
the oxygen. This can change the N-B-O system’s geometry. A hydride on the boron has 
a stronger repulsive effect on the oxygen’s lone pair than a methyl group, possibly 
8because the negative charge is more distributed in the methyl. [8] Other sources explain 
the N-B bond only via the Lewis acidity, Lewis basicity and steric effects of the 
substituents. No other source mentions polarization across the N-B bond or electrostatic 
charge differences between the substituents and the boron and nitrogen. In this thesis’ 
context, the attractive effect caused by the positive charge cloud of the hydrogens bound 
to the nitrogen could mean that the boroxazolidones discussed in the next chapter are 
partially stabilized by this effect.
For an o-(N,N-dialkyl aminomethyl)arylboronate 22, it was found that an aprotic solvent 
is necessary for the formation of the N-B bond. A protic solvent on the other hand 
causes the boron to become a hydrogen bonded zwitterionic species, which forms little 
to no N-B bond at all. [21] 
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Picture 5: Structure of o-(N,N-dialkyl aminomethyl)arylboronate 22 [21]
The N-B bond energy can be studied by such methods as 11B and 14N NMR, dynamic 
NMR, theoretical calculations, microwave spectroscopy, electron diffraction 
crystallography and X-ray crystallography. The N-B bond length can be used to deduce 
the bond strength, and it varies from 1.57 Å to 2.91 Å. The geometry of a tetravalent 
boron changes from a tetrahedral to a trigonal planar, as the N-B bond gets weaker. [19]
2.2.1 Boroxazolidones
Boroxazolidones are a subset of N-B bond-containing compounds. In addition to the 
previously mentioned potentials of boron and N-B bond compounds, boroxazolidones 
have interesting potentials of their own. A boroxazolidone-forming reaction can be used 
to protect the functional groups of an α-amino acid [22] or to turn sensitive alkyl- or 
aryl-substituted boron compounds to more stable solids [23]. Similar molecules, as 
focused on in this thesis, the 2,2-diphenyl-1,3λ4,2λ4,-oxazaborolidin-5-ones 24, have 
been discovered to show cytotoxic activity against the cell lining of colon cancer and 
leukemia cells. [24] They can also be used for dyeing polymer fibers, in the Diels-Alder 
reaction and in other applications [25]. 
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Picture 6: The structure and ring numbering of a general boroxazolidone 1,3λ4,2λ4-
oxazaborolidin-5-one 23, and the structure of  2,2-diphenyl-1,3λ4,2λ4,-oxazaborolidin-
5-one 24 
The naming of compounds similar to 24 differs from reference to reference. An (L)-
valine-derived boroxazolidone with two phenyls at the boron (25) can be called L-
valinatodiphenylboron [2] or 1,1-diphenylboroxazolidone derivate of (L)-valine [26]. 
One name for the boroxazolidone ring 23, which is central to this thesis, is 1-oxa-3-
azonia-2-boranuidacyclopentan-5-one [27]. Two other names for the same ring with 2 
phenyls at the boron are 2,2-diphenyl-1,3-oxazaborolidin-5-one [24] and 2,2-diphenyl-
1,3,2-oxazaborolidin-5-one [28]. For a similar molecule (26), the name 2-
aminoethoxydiphenyl borate is used [29]. With this logic, compound 25 could be called 
2-amino-3-methylbutanoic acid diphenyl borate. Another paper uses the name 2-
aminoethyl diphenylborinate for the exactly same compound (26) [30].
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Picture 7: The structure of a (L)-valine-derived boroxazolidone 25 and 2-
aminoethoxydiphenyl borate 26
The most systematically accurate name for the ring of compound 23 is 1,3λ4,2λ4-
oxazaborolidin-5-one. For heterocyclic compounds, the priority of naming is O>N>B 
and the prefixes are respectively oxa, aza and bora from which the last a can be 
removed. The suffix -olidine is used for fully saturated ring systems containing nitrogen 
and five atoms in the ring. The e from olidine can be removed and finally the suffix -one 
can be added to mark the carbonyl. [31; 32] The λn expression is used to indicate a non-
standard valence of heteroatoms [33], so in this case, λ4 means that the boron and 
nitrogen have a valence of four. Substituents are written before the ring’s name in 
alphabetical order and prefixes such as bis or tri have no effect on the order [31]. For 
compound 25, the systematic name is thus 4-isopropyl-2,2-diphenyl-1,3λ4,2λ4-
oxazaborolidin-5-one. In this thesis, the more trivial name boroxazolidone will be used 
to refer to compounds, which contain the 1,3λ4,2λ4-oxazaborolidin-5-one 23 ring 
structure.
Because of the N-B bond, boroxazolidones are more stable to air and moisture than 
many other organoboron compounds [34]. The carbonyl group further stabilizes the 
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ring. 2-Aminoethoxydiphenyl borate 26 hydrolyzes easily to diphenylborinic acid, but 
this does not happen for the similar amino acid complexes like compound 25. [30] 
When the boron is substituted with aryl groups, the boroxazolidone is more stable 
towards hydrolysis than when the boron is substituted with alkyl groups [22]. The alkyl 
group at the 4-position (R in compound 24) can be important for the properties of the 
boroxazolidone. One study looking at boroxazolidone-induced apoptosis, found that the 
R-group of 2,2-diphenyl-1,3λ4,2λ4,-oxazaborolidin-5-one 24 has an effect on the 
cytotoxicity of the compounds. A glycine-derived boroxazolidone (R is H) was more 
cytotoxic than the (L)-valine-derived boroxazolidone. The heterocyclic ring is the 
biologically active moiety. [28]
There are many routes to make boroxazolidones. Reactions between 1,2- or 1,3-
aminoalcohols and a boron reagent, which can be an alkyl- or arylborinic acid, dialkyl- 
or diarylborinic acid, boronate, borane or borane dimethyl sulfide, are the most common 
method for making boroxazolidones [25]. Another route is to use α-amino acids and 
trialkylboranes [35]. In this thesis, a reaction between an amino acid (L-valine) and a 
triethylammonium tetra-arylborate was used to produce the boroxazolidones. 
A boroxazolidone can be used to produce some chiral α-amino acids. One way to do 
this is by first forming a boroxazolidone from an α-amino acid-derived sodium amidino 
carboxylate 27 by using either potassium phenyltrifluoroborate and trimethylsilyl 
chloride or 1-naphthyltrifluoroborate and trimethylsilyl chloride. This boroxazolidone 
forms as two diastereomers where the configurations of fluorine and phenyl or naphthyl 
at boron are different but the product can be diastereomerically purified to 28a or 28b 
by using crystallization-induced asymmetric transformation (CIAT) and 
recrystallization, which can change the isomer from one to the other while it crystallizes. 
The phenyl and naphthyl-substituted compounds form the diastereomers with opposing 
absolute configuration in boron. This works the best for phenylalanine-derived 
compounds (R1 is benzyl). The boroxazolidone can be reduced by KOtBu to 29, and an 
alkyl halide can be used to add an alkyl group to the double bond to form 30. This alkyl 
group’s diastereomeric configuration is controlled by the position of the phenyl or 
naphthyl at boron so by either using 28a or 28b, one can choose the configuration of the 
alkyl group. The effect where a compound such as 29a, which has no stereogenic center 
at the α-carbon, forms a stereocontrolled product, or in other words, retains 
stereochemical information, is called asymmetric memory. The boroxazolidone ring of 
30 can then be broken with methanol reflux, and the imine can be removed by 
ethylenediamine to afford an enantiomerically highly pure α-amino acid 31a or 31b, 
which works the best when R2 is CH=CH2. [36] The 1-naphthyltrifluoroborate route has 
been shortened in scheme 4 to reduce repetition.
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Scheme 4: Boroxazolidone as an intermediate in the preparation of chiral α-amino 
acids from sodium amidino carboxylates
2-Aminoethoxydiphenyl borate 26 can modulate calcium signaling in the plasma 
membrane of cells. It can both inhibit and stimulate store-operated calcium entry 
depending on the concentration and the oligomeric state of the molecule. The N-B bond 
strength and the ring’s strain together cause the multiple oligomeric forms, which can 
influence different binding sites in a cell membrane. [16] Controlling the intracellular 
Ca2+ concentration might be useful for treating heart disease and Alzheimer’s disease 
[37]. 
Oxazaborolidinium ions containing monophenylboron and methyl-substituted 
quaternary nitrogen can catalyze homologation reactions of ketones to the 
corresponding silyl enol ether and ring expansion of cyclic ketones (scheme 5). Both 
reactions use trimethylsilyldiazomethane. [38] This oxazaborolidinium ion 32 is a 
Lewis acid and it catalyzes the reaction by activating the ketone. The oxazaborolidinium 
ion’s bulkiness inhibits it from reacting with the product, which makes it better for this 
reaction than some other Lewis acids such as ZrCl4. [39]
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Scheme 5: An oxazaborolidinium ion 32, and the homologation of a ketone to silyl enol 
ethers and the ring expansion of a cyclic ketone catalyzed by 32 [39]
Some prochiral ketones can be reduced to chiral secondary alcohols in good yields and 
ee values with catecholborane by using an oxazaborolidine as a catalyst. (L)-Threonine-
derived, t-butyldimethylsilyl ether (TBDMSO) protected oxazaborolidine 43 showed 
the best result (95 % yield, 90 % ee, with 100 mol % of catalyst). Oxazaborolidines 41 
and 42 were not quite as effective (95 % yield, 80 % ee and 93 % yield, 84 % ee 
respectively with 100 mol %). The higher effectiveness of 43 is attributed to the 
bulkiness of the TBDMSO group. [40] 
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Scheme 6: Reduction of prochiral ketone 4-methoxy-4’-(trifluoroacetyl)biphenyl [40]
Polymer-supported oxazaborolidines have shown good results for producing chiral 
alcohols from ketones by reduction with borane (BH3). Turnover number of the catalyst 
was up to 560. [41]
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Picture 8: A Polystyrene-supported oxazaborolidine 44 [41]
2.3 TEATABs
Triethylammonium tetra-arylborates (TEATABs) 47 were used for the boroxazolidone 
preparation because it had been shown that they could be made with different 
substituents in good yields, [12] and that they could be used to produce boroxazolidones 
[3] in good yields. TEATABs had been prepared in the lab before and were known to be 
stable compounds [12]. 
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Scheme 7: The procedure for making TEATABs from various aryl halides by Kuuloja 
[12]
The first procedure for making a boroxazolidone in a similar manner to scheme 8 was 
developed by G. Baum already in 1970 but that reaction utilized sodium 
tetraphenylborate. [42] By changing the cation from sodium to triethylammonium, the 
solubility of the compound changes and its purification becomes easier. In addition to 
developing the method for making boroxazolidones from TEATABs, Kuuloja also 
studied the Suzuki reaction with the TEATABs as reagents and found that the cation 
affects the reactivity of the tetra-arylborate in that reaction. [12]  Two aryl groups are 
lost as the corresponding benzenes in the reaction of scheme 8, so the atom economy of 
this reaction is not very high.
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Scheme 8: The method for boroxazolidone synthesis from TEATABs and (L)-valine 
developed by Kuuloja [3]
In this thesis, the TEATABs are used as reagents but tetra-arylborates can also be used 
in other ways. The first synthesized tetra-arylborate, tetraphenylborate, was used 
already in the 1940s to precipitate cations e.g. potassium, cesium or quaternary 
ammonium compounds. [43; 44] The tetraphenylborate was prepared from 
phenyllithium 51 and triphenylborane 50 in ether. [44]
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Scheme 9: The synthesis of lithium tetraphenylborate 52 developed by Wittig et al. [44]
A more recent study found that tetra-arylborates with differing cations could be used to 
influence the selectivity of potentiometric ion sensors. This might give rise to a new 
family of charged carriers for cation-selective electrodes. Their method of synthesizing 
the tetra-arylborates was similar to that of Kuuloja but instead of adding NaBF4 before 
forming the Grignard, they added boron trifluoride diethyl etherate 53 after forming the 
Grignard. [45]
BF3
-
CH3 O
+ CH3 53
Picture 9: Boron trifluoride diethyl etherate
If one deals with trifluoromethylphenyl Grignard reagents, it is important to know that 
these compounds might decompose in an exothermic explosion with excess magnesium 
metal [46]. A safe method for preparing sodium tetrakis[3,5-
bis(trifluoromethyl)phenyl]borate 55 utilizes isopropylmagnesium chloride (i-PrMgCl) 
instead of magnesium metal. [47]
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Scheme 10: A safe method for preparing tetrakis[3,5-bis(trifluoromethyl)phenyl]borate 
[47]
Fluorinated tetra-arylborates can be used to study very reactive cationic transition-metal 
complexes and have made it possible to use such cation complexes in polymerization 
and other applications. [47]
2.4 Imines
Imines contain a R1R2C=NR3 moiety where the R groups can be hydrogens or alkyl or 
aryl groups. The R3 can additionally be a metal or a metalloid (Si, Al, B, etc.) [48]. A 
subset of imines, in which R3 is not H, is called Schiff bases. Two other subsets of 
imines are the aldimines and ketimines. In aldimines, R1 or R2 is a hydrogen atom and 
the other R is either an alkyl or an aryl group. In ketimines, both the R1 and R2 are alkyl 
or aryl groups. [49]
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Picture 10: Structure of a general imine 56 [49]
Imines are important for many reactions. They can work as electrophiles in such 
reactions as reductions, additions and condensations. Some imines can coordinate to 
metals, and prochiral imines (R1 is different from R2) can be used to make chiral 
amines. [49] In nature, living organisms produce amino acids from keto acids and vice 
versa by a process called transamination, which involves an imine intermediate [48; 50]. 
Applications for imines in organic synthesis include addition reactions, Staudinger 
reactions, hetero Diels-Alder reactions and chiral Salen metal complex synthesis. Imines 
are present in many natural, semi-synthetic and synthetic compounds. [48]
Imines also have applications as medicines. They can have anticancer, antibacterial, 
antifungal, antiparasitic and antiviral activity or can be otherwise important as in the 
case of radionuclide complexes. Specific diseases, that imine-containing compounds 
have shown potential for treating, are malaria, carcinoma, tuberculosis and HIV. [48]
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Imines can be made in multiple ways, such as condensation of an aldehyde or ketone 
with an amine, addition of aryl halides and liquid ammonia to aldehydes or ketones, 
hydroamination of alkynes, oxidative coupling of alcohols and amines, dehydrogenation 
of secondary amines, and coupling of aldehydes or ketones with nitro compounds. [49] 
This thesis focuses on the condensation between aldehydes and amines as the route for 
preparing the imines. Scheme 11 shows the general imine formation reaction from an 
aldehyde 57 and a primary amine 58. The reaction starts by a nucleophilic attack of the 
nitrogen’s lone pair electrons to the carbonyl carbon. Water elimination from the 
hemiaminal intermediate 59 is necessary for the imine 60 formation. Imines can revert 
to their starting materials via hydrolysis. Because of this, water must be removed from 
the reaction mixture in many cases to push the reaction to the right. This can be done 
by, for example, a Dean-Stark apparatus, molecular sieves or dehydrating agents. Lewis 
acids can catalyze the first step of the reaction, possibly by attaching to the carbonyl 
oxygen [51; 52]. Additionally, the Lewis acid can irreversibly bind to water in the later 
step. [49]
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Scheme 11: General imine formation from an aldehyde and a primary amine [49]
Typically, imine formation happens most efficiently at pH 4-6 because a proton is 
needed for the water to leave but too much acidity will protonate the amine and prevent 
the reaction from starting. Usually, an imine must have an aromatic substituent at its 
double bond nitrogen or carbon, or it will decompose easily via hydrolysis. [50]
The imine condensation reaction between benzaldehyde 61 and boroxazolidone 25 has 
some unusual properties. Lewis acids are not effective for catalyzing it, and water 
removal from the reaction mixture is not necessary either because using molecular 
sieves made no difference when Mannoja tested it. A Lewis base (LB) was found to 
catalyze the imine formation between the boroxazolidone and benzaldehyde. [2] A 
Lewis base such as 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) or TBD can transfer 
electron density to an acceptor. Typically, this enhances the nucleophilicity of the 
acceptor but depending on the acceptor atom, this can instead enhance the 
electrophilicity of the acceptor. This means that Lewis bases can catalyze reactions of 
nucleophilic, electrophilic and ambiphilic reagents. [53]
In the reaction with a boroxazolidone, a Lewis base should attack the boron, break the 
N-B bond (compound 64) and thus make the amine more likely to attack the aldehyde’s 
carbonyl. Later, the LB should leave from the boron and the N-B bond should form 
again. Mannoja found that by changing the Lewis base, either the ketimine 65a or the 
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aldimine 65b could be produced. Nitrogen-containing Lewis bases like DBU produced 
the ketimine in the best yields. DBU is also a Brønsted base, which could mean that it 
deprotonates the amine (compound 63) instead of attacking the boron, and catalyzes the 
reaction in this way. In the case of aldimine formation, phosphine-derived Lewis bases 
such as PPh3 worked the best. This could mean that when a Lewis base attacks the 
boron and thus weakens or breaks the N-B bond, the aldimine is the favored product. 
On the other hand, if the Lewis base is also a Brønsted base, it can then isomerize the 
aldimine into the ketimine. Using five equivalents of benzaldehyde was found to 
produce the best yield, and it is more reasonable to use an excess of the aldehyde than 
an excess of boroxazolidone because the boroxazolidone is more valuable. The best 
solvent was found to be 1,2-dichloroethane (DCE) and a temperature of 80 °C. [2]
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Scheme 12: The possible routes of ketimine 65a and aldimine 65b formation from 
boroxazolidone 25 and benzaldehyde 61 via Lewis acid, Brønsted base and Lewis base 
catalysis as suggested by Mannoja [2]
The nomenclature of the imines of this thesis is close to the boroxazolidones. The 
ketimine 65a has an unsatured ring so the -olidine suffix changes to -ole [31], and the 
name benzyl is used to mark the PhCH2- group [54]. Thus the name of 65a becomes 3-
benzyl-4-isopropyl-2,2-diphenyl-1,3λ4,2λ4-oxazaborol-5-one. For the aldimine 65b, the 
ring remains saturated but the substituent PhCH= at nitrogen is called benzylidene [54] . 
Thus aldimine 65b is systematically called 3-benzylidene-4-isopropyl-2,2-diphenyl-
1,3λ4,2λ4-oxazaborolidin-5-one.
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3. RESULTS AND DISCUSSION
This thesis’ experiments were performed in the synthesis laboratory of the Department 
of Chemistry and Bioengineering in Tampere University of Technology during January 
2016 - June 2016. The motivation for this thesis was to deepen the understanding about 
imine condensation between aldehydes and boroxazolidones and about the N-B bond. 
The first three subchapters 3.1, 3.2 and 3.3 contain the important results in regards to 
the motivation of the thesis, and the later subchapters describe the results obtained as a 
byproduct of the research. All successfully prepared imines were isolated by column 
chromatography. The measured 1H and 13C NMR spectra are explained for all prepared 
compounds but the peaks remaining nearly constant are mentioned only once for each 
group of compounds. The NMR explanations do not always cover the aromatic area 
because of its ambiguity. In 13C NMR measurements, all C-H interactions were 
decoupled so these interactions do not produce multiplets.
3.1 Lewis base screening
Mannoja had already optimized the imine formation reaction of boroxazolidone 25 to a 
high degree. She had found a good solvent and the proper temperature. She had found 
that bases work as the catalyst instead of acids, and she had found the proper amounts of 
the aldehyde 61, boroxazolidone 25, catalyst and solvent to be used. She also found that 
bases, which are either Lewis bases or both Lewis and Brønsted bases produced the best 
results. [2] As there were still many untested LBs, more screenings were done to 
determine if some other LB than DBU could achieve a higher yield of the ketimine 65a 
and if some new LB would yield the aldimine 65b.
Ph
Ph
O
N
H2
+
O
B-
+
Ph
O
H
(5 eq)
LB (0.3 - 1.0 eq)
DCE (1.0 - 2.0 ml)
Reflux, 24h
Ph
Ph
O
N+
O
B-
Ph
Ph
Ph
O
N+
O
B-
Ph
+
25 61 65a 65b
Scheme 13: The reaction for Lewis base screening
Scheme 13 shows the procedure for LB screening. Products were obtained as single 
isomers 65a or 65b as determined by 1H NMR. If the isolated yield was too low, or the 
sample was known to be impure from thin-layer chromatography (TLC), 1H NMR was 
not performed. The default order of addition of reagents was boroxazolidone and 
solvent first, then aldehyde and finally LB. The results are shown in table 2.
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First, replicating the result of a 62 % yield of ketimine 65a by Mannoja was attempted. 
This was found to be difficult. The reaction produced multiple product spots on TLC, 
and these products could not be easily separated by column chromatography. Adding 
DBU before benzaldehyde was also attempted (entry 2), as well as using 1.0 eq of DBU 
instead of 0.3 eq (entry 3). However, the yield only worsened, and the problem of 
multiple products remained. Finally, the best result was achieved by using freshly 
distilled DBU and 2 ml of DCE (entry 4). Even then, the yield (46 %) was clearly below 
that of Mannoja’s (62 %). The amount of DCE was increased by 0.5 ml because the 
system was found to lose some solvent during reflux. 
Then, other LBs were tested. Potassium tert-butoxide (t-BuOK) produced a pure 
ketimine 65a but the yield was only 28 % (entry 5). 1,8-Bis(dimethylamino)naphthalene 
(proton sponge) produced a better yield of ketimine 65a (53 %) than DBU, and the 
product was pure (entry 6). 2,4,6-Trimethylpyridine produced three product spots that 
were not isolated (entry 7). TBD was found to be the most effective LB for producing 
the ketimine 65a, with a yield of 57 % (entry 8). After this, the amount of DCE and 
TBD was changed to see if the yield could be further improved but the yield worsened 
and two product spots were seen on TLC every time (entries 9 - 11). Using 0.3 eq of 
TBD and 2 ml of DCE remained as the best choice. This combination gave the best 
yield and only one product spot on TLC. 
Sodium methoxide was found to produce the aldimine 65b. Clear improvement was 
seen, when the amount of LB was increased from 0.3 to 1.0 eq (entries 12 and 13). The 
48 % yield of aldimine 65b with 1.0 eq of NaOMe is an estimate because the aldimine 
easily reverts to its starting materials, which can be seen in the 1H NMR spectrum. 
Moving 65b to a freezer under Ar right after purification might help to preserve it. An 
interesting detail is that bulky potassium tert-butoxide produced a ketimine but sodium 
methoxide produced an aldimine even though they are both alkoxide-bases.
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Table 2: Isolated yields of ketimine 65a or aldimine 65b from the reaction between 
benzaldehyde and boroxazolidone with different Lewis base, equivalents of bases and 
solvent volumes
Isolated yield (%)
Entry LB LB eq. Solvent volume (ml) 65a 65b
1 DBU 0.3 1.5 ~51a -
2 DBU (before aldehyde) 0.3 1.5 ~32a -
3 DBU 1.0 1.5 ~34a -
4 DBU (distilled) 0.3 2.0 46 -
5 t-ButOK 0.3 2.0 28 -
6 Proton sponge 0.3 2.0 53 -
7 2,4,6-Trimethylpyridine 0.3 2.0 - -
8 TBD 0.3 2.0 57 -
9 TBD 0.3 1.0 ~41a -
10 TBD 0.5 1.0 ~20a -
11 TBD 0.1 2 ~9a -
12 NaOMe 0.3 2 - ~18b
13 NaOMe 1 2 - ~48b
a 1H NMR was not done because the yield was too low or because the product was not TLC 
pure after column. b Aldimine had partially reversed to boroxazolidone and benzaldehyde 
when 1H NMR was measured so the product was not pure.
In conclusion, TBD was the best LB for ketimine formation and NaOMe for the 
aldimine formation. However, even with TBD, the result of a 62 % yield of ketimine 
65a reported by Mannoja was not reproducible in this work. Finally, the NMR spectra 
of compounds 25, 65a and 65b are described. The following 13C NMR discussion for 
compounds 25 and 65a is based on Mannoja’s measurements. In this thesis, 13C NMR 
spectra were measured, and placed in the appendix section, for new compounds only.
Boroxazolidone 25 has multiple characteristic 1H NMR peaks in acetone-d6. The two 
doublets at 1.03 (J=6 Hz) and 1.12 ppm (J=9 Hz) are from the isopropyl group’s CH3 
moieties, the multiplet at 2.35 ppm comes from the isopropyl CH moiety and the 
multiplet at 3.71 ppm is from the 4-position CH moiety of the boroxazolidone ring. The 
small broad peaks at 5.7 and 6.7 ppm are from the NH2 moiety. In 13C NMR in DMSO-
d6, 25 shows two singlets at 19.02 and 19.46 ppm from the isopropyl CH3 moieties, a 
singlet at 29.13 ppm from the isopropyl CH moiety, a singlet at 61.04 ppm from the ring 
4-position carbon and a singlet at 174.09 ppm from the carbonyl carbon [2]. 
The characteristic 1H NMR peaks for ketimine 65a in CDCl3 are a doublet at 1.25 ppm 
(J=9 Hz) from the isopropyl CH3 moieties, a quintet at 2.99 ppm (J=6 Hz) from the 
isopropyl CH moiety and a singlet at 5.00 ppm from the benzyl CH2 moiety. In 13C 
NMR in CDCl3, 65a shows one singlet at 17.9 ppm from the isopropyl CH3 moieties, a 
singlet at 30.20 ppm from the isopropyl CH, a singlet at 52.08 ppm from the benzyl 
CH2, a singlet at 162.77 ppm from the heterocycle’s 4-position carbon and a singlet at 
175.78 ppm from the carbonyl carbon [2]. From comparing multiple 13C spectra of 
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different ketimines, it seems that the three singlets at around 133.0, 128.35 and 128.15 
ppm (in CDCl3) correspond to the carbons of the phenyls bound to boron. This helps in 
assigning the rest of the peaks to other carbons. Most likely, the 13C chemical shift of 
the phenyl carbon directly bound to boron, which would be the fourth peak, changes 
depending on the ketimine. For the aldimine 65b in 1H NMR in CDCl3, the isopropyl 
CH3 peaks are further apart than in boroxazolidone and produce two doublets at 0.66 
(J=6 Hz) and 1.20 ppm (J=9 Hz). The most clear characteristic peak of the aldimine 65b 
in CDCl3 is the doublet at 8.88 ppm from the 4-position CH moiety of the ring.
3.2 Effect of different aldehydes on ketimine formation
Next, multiple aldehydes were screened with the newfound TBD to determine the effect 
of the aldehydes’ substituents on ketimine formation. 
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Scheme 14: The reaction for benzaldehyde screening
From table 3, one can see that the halogen-containing benzaldehydes (entries 3, 4 and 7) 
produced a higher ketimine 67 yield than benzaldehyde (entry 1). This is most likely 
due to the electronegative halogen making the carbonyl more electrophilic and thus 
making it more susceptible to an attack from the amine. The other benzaldehydes 
containing electrophilic groups but not halogens (entries 6, 10 and 13), have clearly 
lower yields. The aldehydes substituted with less electrophilic groups (entries 5, 11 and 
12) do not produce any product at all. Interestingly, 4-methoxybenzaldehyde produced a 
decent yield (entry 2) even though methoxy is an electron donating group. 
Seeing that 4-trifluoromethylbenzaldehyde (entry 7) produced the best yield, its 3- and 
2-configurations were also tested (entries 8 and 9). The 2-position should have the same 
electronic effect as the 4-position but the steric hindrance lowers the yield considerably. 
The 3-position has a lower electronic effect than the 4- and 2- positions so the lower 
yield is probably due to this effect.
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Table 3: Yields of ketimines from reactions between different aldehydes and 
boroxazolidone with TBD as the base
Entry Product number Aldehyde Isolated yield (%)
1 65a C6H5CHO 57
2 67a 4-MeOC6H4CHO 40
3 67b 4-BrC6H4CHO 61
4 67c 4-FC6H4CHO 60
5 67d 4-NMe2C6H4CHO -
6 67e 4-NO2C6H4CHO 42a
7 67f 4-CF3C6H4CHO 63
8 67g 3-CF3C6H4CHO 52
9 67h 2-CF3C6H4CHO 8
10 67i 4-CNC6H4CHO 35a
11 67j 2-HOC6H4CHO -
12 67k PhCH=CHO (trans) -
13 67l 4-CO2Me C6H4CHO 43a
a The aldehyde was dissolved in 1 ml of extra DCE prior to addition so the total solvent 
volume was 3 ml
When using a solid aldehyde, it can be beneficial to dissolve the aldehyde to 1 ml of 
DCE prior to adding it to the reaction mixture. In the case of entry 6, the yield increases 
from 18 to 42 % by using this procedure. However, for entry 10, this procedure only 
increases the yield from 31 to 35 %, and entry 3 had a high yield of 61 % even without 
this extra step. In conclusion, there is a correlation between the benzaldehyde’s 
substituent being electron withdrawing and a good imine yield. It is easy to understand 
that electron withdrawing groups increase the yield but for some reason the effect of 
halogen groups is larger than the effect of other EDGs. In addition, 4-
methoxybenzaldehyde does not fit into this correlation at all, as observed in entry 2.
All of the ketimines 67 successfully prepared have similar 1H NMR and 13C NMR 
peaks in CDCl3 as the ketimine 65a already detailed in the previous subchapter 3.1, 
with small variations in chemical shifts. Only the substituent R group changes in the 
spectra. For the fluorine-containing compounds, it is important to know that a carbon 
coupling with fluorines shows a multiplet in 13C NMR because of 19F. This means that 
getting a good quality 13C NMR spectrum from those compounds requires more sample 
and more scans than usually. A carbon coupling to one fluorine atom shows a doublet 
and a carbon coupling to three fluorine atoms shows a quartet. The following picture 11 
numbers the carbons of the ketimine’s benzyl phenyl ring so that further discussion is 
unambiguous. To determine the positions, spectra of similar compounds were searched 
[55].
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Picture 11: Positions of carbons in the benzyl phenyl ring
The following measurements were all performed in CDCl3. 67a shows a characteristic 
CH3 moiety singlet from the methoxy at 3.71 ppm in 1H NMR and at 55.5 ppm in 13C 
NMR. 67b shows no characteristic peaks. 67c shows four characteristic doublets in 13C 
NMR, resulting from coupling with one fluorine, 162.53 ppm (J=247.5 Hz) from 4-
position, 129.64 ppm (J=3.75 Hz) from 1-position, 129.24 ppm (J=7.5 Hz) from 2- and 
6-positions and 116.20 ppm (J=22.5 Hz) from 3- and 5-positions. 65e shows no clear 
characteristic 1H or 13C peaks but the carbon of the benzene ring connected to the nitro 
group does shift to lower field, and it is at 147.76 ppm in 13C. 65f shows three 
characteristic 13C quartets from coupling with three fluorines, 130.77 ppm (J=33 Hz) 
from 4-position, 126.05 ppm (J=3.8 Hz) from 3- and 5-positions and 123.79 (J=271 Hz) 
from the CF3 moiety. Finding the quartets resulting from coupling with three fluorines 
of the trifluoromethyl can be difficult. Especially the trifluoromethyl moiety’s carbon 
peaks can be very small even with a large amount of sample and a high number of 
scans. 65g and 65h have the same kind of characteristic peak systems as 65f in 13C but 
they show only nine peak systems instead of the expected eleven. The CF3 moiety 
quartet for 65g and 65h cannot be found. The quartet is most likely hidden in the 
background noise because the amount of sample was too small. 65g shows quartets at 
131.71 ppm (J=33.7 Hz) from the 3-position, at 125.44 ppm (J=3.7 Hz) from the 2- or 
4-position and at 123.93 ppm (J=4.0 Hz) from the 2- or 4-position. One singlet of the 
65g’s 1-, 6- or 5-position is overlapping something else. 65h shows quartets at 131.90 
ppm (J=1.5 Hz) from the 1- or 3-position and at 126.47 ppm (J=6 Hz) from the 1- or 3-
position. The 2-position quartet and one singlet from the 4-, 5- or 6-position cannot be 
found. The quartet is most likely too small and the singlet overlaps something else. 65i 
shows a singlet in 13C NMR for the cyano group probably at 118.03 ppm. 65l has a 
characteristic 1H NMR singlet at 3.87 ppm from the carboxylate methyl moiety and two 
characteristic 13C NMR singlets from the carbonyl of the carboxylate at 166.35 ppm and 
from the carboxylate methyl at 52.48 ppm.
3.3 Effect of different boroxazolidones on ketimine formation
Then, forming ketimines from four additional boroxazolidones with benzaldehyde and 
TBD was tested. The substituents of the boron should affect the N-B bond, and thus the 
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amine, and finally the ketimine formation. Of all of these boroxazolidones, only the 2,4-
difluoro-substituted 49d dissolves easily into DCE whereas the others need warming 
and still do not dissolve completely.
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Scheme 15: The reaction for boroxazolidone screening
One could expect that electron donating groups in the phenyl rings of 49 would reduce 
the Lewis basicity of the boron and thus weaken the N-B bond. As the N-B bond 
weakens, the nucleophilicity of the nitrogen should increase and the yield from imine 
condensation should increase as well.  However, the results seen in table 4 from these 
reactions do not support this idea. The difference between the phenylboron having 
electron-withdrawing fluoro groups (entry 5) or an electron-donating methyl group 
(entries 2 and 3) is very small. When the phenylboron is substituted with the most 
electron donating group in this series, methoxy, the yield clearly decreases (entry 4). A 
side product forms in entry 4, unlike in other imine formation reactions done with TBD 
as the base. A side product always lowers the yield in these reactions.
Table 4: Yields of ketimines from reactions between benzaldehyde and different 
boroxazolidones with TBD as the base
Entry Product number R Isolated yield (%)
1 65a H 57
2 68a 4-Me 48
3 68b 3-Me 60
4 68c 4-MeO 29
5 68d 2,4-F 52
The following measurements were performed in CDCl3. 68a has a characteristic methyl 
moiety singlet at 2.35 ppm in 1H NMR and at 21.51 ppm in 13C NMR. 68b also has a 
characteristic methyl moiety singlet at 2.32 ppm in 1H NMR at 21.91 ppm, in 13C NMR. 
68b’s 13C spectrum has two overlapping aryl carbon singlets. 68c has a characteristic 
methoxy moiety singlet at 3.81 ppm in 1H NMR. In 13C NMR, 68c has a methoxy 
singlet at 55.32 ppm and a singlet from an aryl carbon bound to the methoxy at 159.67 
ppm. 68d has four characteristic doublets of doublets in 13C NMR from C-F coupling, at 
166.55 (J=168.0, 12.8 Hz), 163.30 (J=174.4, 12.4 Hz), 111.65 (J=19.1, 3.4 Hz) and 
103.40 ppm (J=30.0, 24.0 Hz). Of these, the first two correspond to the carbons bound 
to fluorines and the last two most likely correspond to the meta-positions of which the 
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second one (103.40 ppm) is the carbon between the carbons bound to fluorine. The 
multiplet at 136.69 - 137.24 ppm most likely contains the peaks from the remaining two 
carbons of the borophenyl. The 13C NMR of 68d shows three peaks for the benzyl CH2 
moiety at 52.0 ppm but there should be just one singlet. This might be due to the 
fluorines coupling with this carbon.
3.4 TEATABs
Multiple different TEATABs were made to be used for preparing the corresponding 
boroxazolidones. Scheme 16 shows the procedure for TEATAB synthesis developed by 
Kuuloja.
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Scheme 16: General procedure for TEATAB synthesis
Table 5 shows the yields of different TEATABs. It is difficult to say, which aryl 
bromide is the best for this reaction, because the TEATAB yield depends on the 
solubility difference between the sodium tetra-arylborate (NaTAB) and the 
corresponding TEATAB. All of the successful reactions consumed all or almost all of 
the magnesium flakes so the Grignard formation should not be the limiting step in any 
of these yields.
The tetraphenylborate of entry 1 seems to have the largest solubility difference between 
its sodium and triethylammonium salts in a 1:1 water/methanol solvent system because 
it precipitates so easily and thus produces a very high yield, once triethylamine is added. 
The low yield from entry 2 is due to using too much solvent when the reaction was 
scaled up from Kuuloja’s paper. Increasing the yield of entry 2 was attempted by adding 
pure triethylamine to the filtrate after filtering out the precipitated solid. More solid did 
form into the solution but it was not pure. Generally, it seems that to get a pure product 
in good yield, one must be careful not to use too much solvent in the last step and just 
filter out any insoluble material before adding triethylamine. If the product does not 
precipitate, a refrigerator or a freezer can be used. Removing solvent by evaporation, 
which mostly removes the methanol, could help precipitate the TEATAB but it might 
also produce an impure mixture because the NaTAB might also precipitate.
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Table 5: Yields and used solvent systems for TEATABs
Entry Product number R Solvent Isolated yield (%)
1 47a H 1:1 H2O/MeOH 95a
2 47b 4-MeO 1:1 H2O/MeOH 13
3 47c 4-Me 1:1 H2O/MeOH 66
4 47d 3-Me 1:1 H2O/MeOH 67
5 2,4-F
2:1 
CH3CN/MeOH
-
6
47e
2,4-F 1:1 H2O/MeOH 46
7 4-CN - -
8
47f
4-CN - -
9 4-F3CSO3
First 1:1 
H2O/MeOH
Then 2:1 
H2O/THF
-
10
47g
4- F3CSO3
First MeOH
Then Et3N
Then H2O
-
a Prepared from commercial sodium tetraphenylborate, not from bromobenzene
Attempts to start the Grignard reaction with 4-bromobenzonitrile (entry 7) failed. 
Literature was searched and an alternative method [56] was found that used a lower 
temperature and diethyl ether instead of THF (entry 8) but it did not work either. This 
alternative method also had a problematic issue with the solubility of 4-
bromobenzonitrile to diethyl ether, and it seemed that the authors had possibly made a 
mistake with either the amount of diethyl ether or bromobenzonitrile. Activating the Mg 
was also attempted for entry 8 by grinding it under Ar to a fine powder. The Grignard 
reaction for the 4-bromobenzotriflate worked but the final TEATAB 47g did not 
precipitate. The mixture did not dissolve into a water/methanol mixture almost at all 
(entry 9) so using only methanol, then adding triethylamine, and finally adding water 
was attempted (entry 10). Some precipitation was achieved in entry 10 and a small 
amount of solid was removed with a centrifuge but it was not pure in 1H NMR. The 
spectrum suggests a mixture of tetra- and triarylborate.
TEATAB NMR measurements were performed in acetone-d6 because of their higher 
solubility to it than to chloroform. All of the TEATABs except 47a have a characteristic 
triplet in 1H NMR at around 1.4 ppm corresponding to the triethylammonium’s CH3 
moiety and a quartet at around 3.4 ppm corresponding to the triethylammonium’s CH2 
moiety. For 47a, these peaks are broad but they have the same integrals and are at the 
same positions. In 13C NMR, all TEATABs have two singlets at around 9 and 48 ppm, 
corresponding to the triethylammonium’s CH3 and CH2 moieties, respectively. 47b has 
a characteristic methoxy CH3 moiety singlet at 3.66 ppm in 1H NMR and at 54.87 ppm 
in 13C NMR. The 13C NMR information for 47a and 47b is from Kuuloja’s 
measurements [12]. 47c and 47d both have characteristic CH3 methyl moiety singlets at 
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2.17 and 2.13 ppm in 1H NMR and at 20.65 and 21.60 ppm in 13C NMR, respectively. 
Unlike in boroxazolidones and ketimines, 11B causes some phenyl carbons to show 
quartets in 13C NMR for all the TEATABs. For 47c and 47d, the quartet corresponding 
to the carbon bound to boron is at 161.17 (J=49.0 Hz) and 164.52 ppm (J=49.0 Hz), 
respectively. For 47c and 47d, the other phenyl carbons except the para-position also 
show quartets. 
For 47e, the carbons bound to the fluorines do not show a quartet from the boron but 
instead they just show doublets of doublets at 166.12 ppm (J=240.8, 10.5 Hz) and at 
160.93 (J=237.0, 12.8 Hz) from the fluorine coupling. Three other carbons show 
coupling with boron and fluorine which forms doublets of quartets at 108.20 ppm 
(J=15.0, 3.3 Hz), 101.31 ppm (J=22.9, 1.6 Hz) and 100.89 ppm (J=23.3, 1.5 Hz). One 
could even expect to see doublets of doublets of quartets from a carbon coupling with 
two fluorines and one boron but such systems are not visible. The area at 137.66 - 
137.98 ppm probably shows the peak systems for two carbons.
3.5 Boroxazolidones
The TEATABs 47 and (L)-valine 48 were used to produce different boroxazolidones. 
Scheme 17 shows the boroxazolidone formation reaction developed by Kuuloja.
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Scheme 17: General procedure for boroxazolidone synthesis
This reaction has the same sort of problem as the TEATAB synthesis in that a good 
yield and ease of isolation of product depend on the low solubility of the 
boroxazolidone to the solvent (toluene). The non-substituted boroxazolidone 25 clearly 
had the lowest solubility in toluene and its purification was very easy. 49b also 
precipitated rather quickly from the toluene but more slowly than 25. 49a had to be 
placed in a freezer to induce crystallization, and 49c had to be recrystallized from 
toluene and placed in a freezer before any solid could be filtered out. As precipitation 
becomes harder to achieve, also the yield drops. Finally, 49d does not precipitate even 
after recrystallization and being kept in a freezer for multiple days. Because of this, 49d 
had to be purified by column chromatography, resulting in isolation of the desired 
product in reasonably good 73 % yield.
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Table 6: Yields of different boroxazolidones
Entry Product number R Isolated yields (%)
1 25 H 95
2 49a 4-Me 78
3 49b 3-Me 85
4 49c 4-MeO 47
5 49d 2,4-F 73a
a Column chromatography was needed for purification.
49d is also different from the other boroxazolidones, in that, once evaporated to dry, it 
forms an oily substance instead of a crystalline solid like almost all the other chemicals 
prepared in this thesis. However, once 49d is sufficiently dry after days in a desiccator, 
the oily substance breaks down into a powder.
Characteristic NMR for 25 was already explained in the Lewis base screening 
subchapter 3.1, and the peaks stay nearly the same for all boroxazolidones except for the 
substituent at phenylboron. The following 1H measurements are in acetone-d6 and 13C 
measurements are in DMSO-d6, unless otherwise stated. For 1H NMR, acetone is 
favorable to DMSO because it does not overlap with any peaks. DMSO is better for 13C 
NMR because some boroxazolidones have better solubility to DMSO than to acetone 
and because DMSO does not overlap with any peaks in 13C NMR. The 13C NMR 
measurements for all boroxazolidones are different from the corresponding ketimines’ 
measurements. In ketimines, the isopropyl CH3 moieties and the phenyls at boron are 
symmetrical so the carbons at equal positions show only one singlet However, for the 
boroxazolidones, both the isopropyl CH3 moieties and the phenyls connected to the 
boron are asymmetrical. For 49a, also the methyl CH3 moieties at the phenyls are 
asymmetrical. Compounds 49a, 49b and 49c do not have any substituents, which might 
couple with the carbons. These 13C peak systems of the boroxazolidones show up as 
pairs, which are close to each other. The term “pair”, as used here, does not imply 
multiplicity like the term “doublet” would. These pairs only make sense if they are from 
carbons with the same positions.
49a and 49b show a characteristic methyl CH3 moiety singlet at 2.25 ppm in 1H NMR.  
In 13C NMR, 49a shows a pair of singlets at 21.57 and 21.53 ppm but 49b shows just 
one singlet at 22.10 ppm, corresponding to the methyl moiety. 49c has a characteristic 
methoxy CH3 moiety singlet at 3.74 ppm in 1H NMR and at 55.38 ppm in 13C NMR. 
Boroxazolidones 25, 49a, 49b and 49c have two singlets at around 19.4 and 19.0 ppm 
in 13C NMR, corresponding to both of the isopropyl CH3 moieties. For 49d, these 
singlets are at 18.19 and 17.26 ppm. 49a should show four pairs of singlets in the 
aromatic area but it shows only three pairs. The fourth pair is probably overlapping the 
other three. 49b shows five pairs of singlets but it should have six pairs so the sixth is 
probably overlapping with the others. 49c has three pairs of singlets of which the pair at 
158.61 and 158.60 ppm is the phenyl carbon bound to the methoxy. This leaves just two 
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pairs of singlets, instead of the expected three pairs, to account for the other carbons so 
one of the pairs must again overlap the others.
49d’s 13C spectrum (in acetone-d6) has multiple differences to the other 
boroxazolidones’ 13C spectra. It shows two peaks at 17.26 (one isopropyl CH3 moiety) 
and 60.75 ppm (heterocycle 4-position) instead of the expected one peak for each. This 
cannot be about asymmetry and happens due to something else. The isopropyl CH 
moiety singlet is under the acetone peaks, which are at 28.5 - 30.0 ppm. The fluorine-
substituted phenyl carbons produce doublets of doublets just like in the case of 49c but 
this time there are pairs of doublets of doublets from both phenyls at 166.21 (J=196.1, 
11.6 Hz), 166.18 (J=195.0, 12.0 Hz), 162.99 (J=200.6, 11.6 Hz) and 162.95 ppm 
(J=199.1, 12.4 Hz). One of the phenyl carbon positions forms a pair of triplets at 110.78 
(J=3.8 Hz) and 110.53 ppm (J=3.4 Hz) instead of the expected pair of doublets of 
doublets. Another phenyl carbon produces the expected pair of doublets of doublets at 
102.68 (J=29.6, 24.4 Hz) and 102.65 ppm (J=29.3, 24.8 Hz). Unlike with 49a, 49b and 
49c, 49d’s spectrum shows all the peak systems for all benzene carbons.
3.6 Other results
4-Bromobenzotriflate 70 was prepared in 90% yield for making the corresponding 
TEATAB. Scheme 18 shows the procedure used [57].
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Scheme 18: 4-Bromobenzotriflate 70 preparation [57]
Trifluoromethane sulfonic anhydride is very reactive and produces hydrogen fluoride 
gas so one should be extra careful with this reaction. The product shows a characteristic 
CF3 moiety quartet in 13C NMR at 118.91 (J=319 Hz) in CDCl3.
4-Carboxybenzaldehyde 71 was protected to methyl benzaldehyde-4-carboxylate 72 in a 
75 % yield to be used in the corresponding imine condensation (table 3, entry 13). 
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Scheme 19: Protection of 4-carboxybenzaldehyde’s carboxyl group
It was surprisingly difficult to get this one pure because it easily produced two product 
spots or then some dimethyl sulfate or its degradation products stayed in the product 
regardless of washes. The product has a characteristic CH3 moiety singlet in 1H NMR at 
3.96 ppm in CDCl3.
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4. EXPERIMENTAL
All reagents, except those prepared in the lab and described in this paper, and solvents 
were obtained from Sigma-Aldrich, Aldrich, Fluka, Merck or Tokyo Chemical 
Industries. All reagents and solvents were used as is unless otherwise stated. Reagent 
purity was generally > 95 %. All water used was milli-Q. All glassware was rinsed with 
acetone and dried in an oven or with a heat gun prior to the reactions.
TLC was performed to follow the reactions. The plates were aluminum pre-coated with 
silica gel (Merck TLC silica gel 60 F254). Detection was done primarily with UV light. 
Staining was sometimes done with cerium molybdate for general detection and with 
ninhydrin for detecting amines (boroxazolidones). Column chromatography was 
performed on Merck silica gel 60 (0.040 - 0.063 mm).
All compounds were characterized by 1H NMR to assess their structure and purity. 13C 
NMR spectra of all new compounds were also recorded. Used solvents were CDCl3, 
DMSO-d6 and acetone-d6. The used machinery is a Varian Mercury 300 MHz 
spectrometer. The internal standard for chemical shift δ (ppm) reference was 
trimethylsilane. All mentions of just ether mean diethyl ether.
4.1 TEATAB preparation
A paper from Kuuloja et al. [12] was used as the basis for all TEATAB preparations. 
Grignard reactions were always performed under Ar and with dried solvents. Mg flakes 
were not activated in any way beforehand. Flakes are preferable to powdered Mg 
because one can see the color changes inside the flask i.e. when the reaction starts. As 
usually, the Grignard reactions should be started carefully as not to cause too much 
boiling. 
The THF used for the Grignard reaction was dried in the following way: First, it was 
pre-dried by stirring with NaOH overnight and distilled over the NaOH. Then, sodium 
flakes were added to the distilled THF, the system was refluxed, benzophenone was 
added, the system was refluxed some more and a blue color emerged. Ether was dried 
over sodium in presence of benzophenone as indicator.
4.1.1 Triethylammonium tetraphenylborate (47a)
11g (32 mmol, 1.0 eq) of commercial sodium tetraphenylborate was dissolved to 100 ml 
of MeOH/water (1:1). After the NaBPh4 had dissolved, 200 ml of aqueous 2.5 wt% 
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solution of triethylamine (1.5 eq) was added dropwise while stirring. The solution 
changed to white and milky, and it was stirred overnight. After 20 h, the solid was 
filtered and washed with 3 x 20 ml of water. The product was dried in high vacuum. 
White powder (12.77 g, 95 % yield); 1H NMR (300 MHz, acetone-d6) δ (ppm): 7.35 (d, 
J=3 Hz, 8H), 6.94 (t, J=7.5 Hz, 8H), 6.77 - 6.81 (m, 4H), 3.36 (br. s., 6H), 1.35 (br. s., 
9H). Appendix 1. Spectrum corresponds to Kuuloja’s spectrum [12].
4.1.2 Triethylammonium tetra(4-methoxyphenyl)borate (47b)
In addition to the paper of Kuuloja et al. [12], a lab book note NK-629 was used to 
determine the best procedure. 3.59 g (147.7 mmol, 2.0 eq) of Mg turnings, an iodine 
crystal and 9 ml of THF (did not turn blue but should have been dry) were added to a 2-
neck flask. 18.5 ml (147.7 mmol, 2.0 eq) of 1-bromo-4-methoxybenzene was mixed 
with 30 ml of THF in a dropping funnel. The flask was lowered to an oil bath to help 
initiate the Grignard formation. 1/10 of the 1-bromo-4-methoxybenzene solution was 
added dropwise. Boiling started, and the rest of the solution was added slowly. Oil bath 
temperature was around 75 ºC. After 4 hours, the flask was raised to cool, and 2.02 g 
(18.5 mmol, 1.0 eq) of sodium tetrafluoroborate was added by quickly raising the 
condenser and pouring it in. The system was stirred overnight at room temperature for 
21 h. 
The solution was quenched into 880 ml of 4:1:200 Na2CO3/NaOH/water solution while 
stirring. The solution was saturated with NaCl and extracted with 2 x 100 ml and 3 x 50 
ml of ether. The ether was washed with brine (saturated aqueous sodium chloride 
solution) and evaporated. The solid was dissolved to 500 ml of 1:1 MeOH/water 
solution and filtered twice through celite. 200 ml of MeOH was added to get a clear 
solution. 230 ml of 2.5 wt% triethylamine (3.0 eq) solution was added. The solution was 
stirred overnight. No solid formed. Some solvent was evaporated in a rotavaporator. 
Precipitate formed, and it was filtered and washed with water and hexane. White solid 
(1.36 g, 13 % yield); 1H NMR (300 MHz, acetone-d6) δ (ppm): 7.17 - 7.22 (m, 8H), 
6.52 - 6.57 (m, 8H), 3.66 (s, 12H), 3.42 (quar, J=9 Hz, 6H), 1.38 (t, J= 7.5 Hz, 9H). 
Appendix 2. 
4.1.3 Triethylammonium tetra(4-methylphenyl)borate (47c)
THF was the same as used with 47b. 2.878 g (26.2 mmol, 1.0 eq) of sodium 
tetrafluoroborate, 2.552 g (104.7 mmol, 1.0 eq) of Mg turnings, an iodine crystal and 6 
ml of THF were set to a flask. 18.24 g (104.7 mmol, 1.0 eq) of 4-bromotoluene was 
mixed with 58 ml of THF and set to dropping funnel. The flask was lowered to a 75 ºC 
oil bath, and the bromotoluene solution was slowly added. Vigorous boiling began after 
half of the solution had been added. The solution was refluxed for 1 h, and it was left to 
stir at room temperature for 16 h. The reaction mixture was quenched to 70 ml of 
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4:1:200 Na2CO3/NaOH/water solution while stirring. The THF layer was removed. The 
water layer was saturated with NaCl and extracted with 4 x 60 ml of ether. The ether 
and THF are combined and washed with 100 ml of brine. The organic layer was 
evaporated, and the resulting solid was dissolved to 300 ml of MeOH/water solution. 
The solution was filtered through celite to get a clear solution. 70 ml of 10 wt% aqueous 
triethylamine (68.1 mmol, 2.6 eq) solution, with 10 ml of MeOH to avoid separation of 
the triethylamine and water into layers, was added slowly to the solution. A white 
precipitate formed, and the solution was stirred for 2.5 h. The solid was filtered and 
washed with hexane and water. White solid (8.3 g, 66 % yield); 1H NMR (300 MHz, 
acetone-d6) δ (ppm): 7.20 - 7.25 (m, 8H), 6.74 (d, J=9 Hz, 8H), 3.32 (quar, J=7.0 Hz, 
6H), 2.17 (s, 12H), 1.33 (t, J=7.5 Hz, 9H); 13C NMR (75 MHz, acetone-d6) δ (ppm): 
161.17 (quar, J=49.0 Hz), 136.37 (quar, J=1.5 Hz), 129.37 (s), 126.14 (quar, J=2.8 Hz), 
47.38 (s), 20.65 (s), 8.79 (s). Appendices 3, 4a and 4b.
4.1.4 Triethylammonium tetra(3-methylphenyl)borate (47d)
2.549 g (104.7 mmol, 1.0 eq) of Mg turnings, 2.881 g (26.2 mmol, 1.0 eq) of sodium 
tetrafluoroborate, an iodine crystal and 6 ml of THF were added to a flask. 12.7 ml 
(104.7 mmol, 1.0 eq) of 3-bromotoluene was dissolved to 58 ml of THF in a dropping 
funnel. 1/5 of the bromotoluene solution was added to the solution, and boiling started 
already even though the oil bath’s temperature was only 30 ºC. The oil bath was 
removed, and the rest of the solution was added at a suitable pace to keep the boiling 
going. Left to stir at room temperature for 18 h. The rest of the procedure goes just like 
with 47c. White solid (8.37 g, 67 % yield); 1H NMR (300 MHz, acetone-d6) δ (ppm): 
7.21 - 7.23 (m, 4H), 7.13 - 7.18 (m, 4H), 6.82 (t, J=7.5 Hz, 4H), 6.60 (d, J=6 Hz, 4H), 
3.32 (quar, J=7.0 Hz, 6H), 2.13 (s, 12H), 1.33 (t, J=7.5 Hz, 9H); 13C NMR (75 MHz, 
acetone-d6) δ (ppm): 164.52 (quar, J=49.0 Hz), 137.16 (quar, J=1.5 Hz), 133.76 (quar, 
J=1.5 Hz), 132.97  (quar, J=2.8 Hz), 125.16 (quar, J=3.0 Hz), 122.24 (s), 47.42 (s), 
21.80 (s), 8.73 (s). Appendices 5, 6a and 6b.
4.1.5 Triethylammonium tetra(2,4-difluorophenyl)borate (47e)
0.973 g (40 mmol, 1.0 eq) of Mg turnings, 1.09 g (9.96 mmol, 1.0 eq) of sodium 
tetrafluoroborate, an iodine crystal and 3 ml of THF (freshly distilled, blue color) were 
added to a flask. 4.5 ml (40 mmol, 1.0 eq) of 1-bromo-2,4-difluorobenzene was 
dissolved to 26 ml of THF in a dropping funnel. The flask was lowered to a 90 ºC oil 
bath, 1-bromo-2,4-difluorobenzene solution was added until boiling began, and the oil 
bath was removed. Rest of the solution was added dropwise, and the mixture was left to 
stir for 23 h. The mixture was quenched to 40 ml of 4:1:200 Na2CO3/NaOH/water 
solution while stirring. The THF layer was removed. The water layer was saturated with 
NaCl and extracted with 4 x 30 ml of ether. The ether and THF were combined and 
washed with 50 ml of brine. The organic layer was evaporated the resulting orange 
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sludge was dissolved to 300 ml of MeOH/water solution. The solution was filtered 
through celite to get a clear solution. The liquid did not come through as clear so an 
additional 60 ml of MeOH was added, and the solution was filtered again through celite. 
The liquid was now clear. A solution of triethylamine/water/MeOH (3.6/23/3.6 ml) was 
added slowly. The solution was stirred overnight and placed in freezer. The precipitate 
was filtered and washed with water + hexane. Creamy solid (2.64 g, 46 % yield); 1H 
NMR (300 MHz, acetone-d6) δ (ppm): 7.17 - 7.27 (m, 4H), 6.57 - 6.63 (m, 4H), 6.38 - 
6.45 (m, 4H), 3.44 (quar, J=6 Hz, 6H), 1.39 (t, J=7.5 Hz, 9H); C NMR (75 MHz, 
acetone-d6) δ (ppm): 166.12 (dd, J=240.8, 10.5 Hz), 160.93 (dd, J=237.0, 12.8 Hz), 
137.66 - 137.98 (m), 108.20 (dquar, J=15.0, 3.3 Hz), 101.31 (dquar, J=22.9, 1.6 Hz), 
100.89 (dquar, J=23.3, 1.5 Hz), 47.38 (s), 8.71 (s). Appendices 7, 8a and 8b. 
4.2 Boroxazolidone preparation
Unpublished research from Kuuloja [3] was used as the basis for preparing these 
boroxazolidones from the corresponding TEATABs.
4.2.1 4-isopropyl-2,2-diphenyl-1,3λ4,2λ4-oxazaborolidin-5-one 
(25)
1.283 g (11.0 mmol, 1.0 eq) of (L)-valine and 230 ml of toluene were mixed with 4.615 
g (11.0 mmol, 1.0 eq) of non-substituted TEATAB 47a. The solution was refluxed at 
120 ºC for 18 h and stirred at room temperature for 4 h. The solid was filtered and 
washed with 10 ml of water and 10 ml of toluene. White solid (2.94 g, 95% yield); 1H 
NMR (300 MHz, acetone-d6) δ (ppm): 7.46 - 7.50 (m, 4H), 7.12 - 7.24 (m, 6H), 6.74 
(br. s., 1H), 5.67 (br. s., 1H), 3.68 - 3.75 (m, 1H), 2.31 - 2.42 (m, 1H), 1.12 (d, J=9 Hz, 
3H), 1.03 (d, J=6 Hz, 3H). Appendix 9. The spectrum corresponds to Mannoja’s 
spectrum.
4.2.2 4-isopropyl-2,2-bis(4-methylphenyl)-1,3λ4,2λ4-
oxazaborolidin-5-one (49a)
0.323 g (2.72 mmol, 1.0 eq) of (L)-valine and 1.30 g (2.72 mmol, 1.0 eq) of 4-methyl 
substituted TEATAB 47c were mixed with 65 ml of toluene. The solution was refluxed 
for 19 h at 120 ºC. No solid could be seen, so the solution was evaporated, and the solid 
was recrystallized with toluene. The solution was placed in a fridge. Solid formed, and 
it was filtered. The solution was evaporated again, and even less toluene was used to 
recrystallize again. After 2 days in a freezer, more solid could be filtered out from the 
solution. The solids were washed with water and toluene. After checking 1H NMR, the 
fractions were combined. White solid (0.66 g, 78 % yield); 1H NMR (300 MHz, 
acetone-d6) δ (ppm): 7.33 - 7.37 (m, 4H), 7.01 - 7.05 (m, 4H), 6.61 (br. s., 1H), 5.53 (br. 
s., 1H), 3.66 - 3.73 (m, 1H), 2.32 - 2.40 (m, 1H), 2.25 (s, 6H), 1.12 (d, J=6 Hz, 3H), 
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1.03 (d, J=6 Hz, 3H); 13C NMR (75 MHz, DMSO-d6) δ (ppm): 174.11 (s), 135.31 (s), 
135.24 (s), 132.03 (s), 131.97 (s), 128.32 (s), 128.25 (s), 61.01 (s), 29.11 (s), 21.57 (s), 
21.53 (s), 19.43 (s), 18.93 (s). Appendices 10, 11a and 11b.
4.2.3 4-isopropyl-2,2-bis(3-methylphenyl)-1,3λ4,2λ4-
oxazaborolidin-5-one (49b)
0.320 g (2.72 mmol, 1.0 eq) of (L)-valine and 1.30 g (2.72 mmol, 1.0 eq) of 3-methyl 
substituted TEATAB 47d were mixed with 65 ml of toluene. The solution was refluxed 
for 18 h at 120 ºC. Solid precipitated after the solution had cooled down for 3 h at room 
temperature. The solid was filtered and washed with water and toluene. White solid 
(0.71 g, 85 % yield); 1H NMR (300 MHz, acetone-d6) δ (ppm): 7.26 - 7.30 (m, 4H), 
7.09 (t, J=7.5 Hz, 2H). 6.94 - 6.97 (m, 2H), 3.66 - 3.73 (m, 1H), 2.30 - 2.41 (m, 1H); 
2.25 (s, 6H), 1.12 (d, J=6 Hz, 3H), 1.02 (d, J=9 Hz, 3H); 13C NMR (75 MHz, DMSO-
d6) δ (ppm): 174.06 (s), 136.10 (s), 135.98 (s), 132.53 (s), 132.49 (s), 128.95 (s), 128.93 
(s), 127.61 (s), 127.54 (s), 127.25 (s), 127.19 (s), 61.01 (s), 29.10 (s), 22.10 (s), 19.46 
(s), 19.03 (s). Appendices 12, 13a and 13b.
4.2.4 4-isopropyl-2,2-bis(4-methoxyphenyl)-1,3λ4,2λ4-
oxazaborolidin-5-one (49c)
0.26 g (2.4 mmol, 1.0 eq) of (L)-valine, 1.17 g (2.2 mmol, 0.9 eq) of 4-methoxy 
substituted TEATAB 47b and 65 ml of toluene were refluxed at 120 ºC for 23 h. Some 
solid precipitated but it was not enough. The solution was evaporated, and the solid was 
recrystallized from toluene. Some solid remained undissolved, and the solution was 
filtered as boiling hot. Evaporated and recrystallized again. After 3 h in a freezer, a solid 
formed, and it was washed with water and toluene. White solid (0.35 g, 47 % yield); 1H 
NMR (300 MHz, acetone-d6) δ (ppm): 7.34 - 7.39 (m, 4H), 6.77 - 6.82 (m, 4H), 3.74 (s, 
6H), 3.67 - 3.73 (m, 1H), 2.31 - 2.40 (m, 1H), 1.12 (d, J=6 Hz, 3H), 1.03 (d, J=6 Hz, 
3H); 13C NMR (75 MHz, DMSO-d6) δ (ppm): 174.16 (s), 158.61 (s), 158.60 (s), 133.24 
(s), 133.13 (s), 113.32 (s), 113.24 (s), 60.99 (s), 55.38 (s), 29.10 (s), 19.44 (s), 18.84 (s). 
Appendices 14 and 15.
4.2.5 4-isopropyl-2,2-bis(2,4-difluorophenyl)-1,3λ4,2λ4-
oxazaborolidin-5-one (49d)
0.28 g (2.3 mmol, 1.0 eq) of (L)-valine, 1.31 g (2.3 mmol, 0.9 eq) of 2,4-difluoro-
substitituted TEATAB 47e and 65 ml of toluene were refluxed at 130 ºC for 18 h. 
Recrystallization in toluene did not work. The product had to be purified by column 
chromatography. The reaction mixture was mixed with silica and dried. 20 cm silica 
was used, and the starting eluent was 1:3 AcOEt/hexane. White/brown oil, later solid 
white power (603 mg, 73 % yield); 1H NMR (300 MHz, acetone-d6) δ (ppm): 7.23 - 
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7.32 (m, 2H), 6.78 - 6.99 (m, 4H), 5.93 (br. s., 1H), 3.85 - 3.92 (m, 1H), 2.37 - 2.46 (m, 
1H), 1.12 (d, J=6 Hz, 3H), 1.08 (d, J=6 Hz, 3H); 13C NMR (75 MHz, acetone-d6) δ 
(ppm): 172.27 (s), 166.21 (dd, J=196.1, 11.6 Hz), 166.18 (dd, J=195.0, 12.0 Hz), 162.99 
(dd, J=200.6, 11.6 Hz), 162.95 (dd, J=199.1, 12.4 Hz), 135.60 - 136.01 (m), 110.78 (t, 
J=3.8 Hz), 110.53 (t, J=3.4 Hz), 102.68 (dd, J=29.6, 24.4 Hz), 102.65 (dd, J=29.3, 24.8 
Hz), 60.77 (s), 60.75 (s), 18.19 (s), 17.26 (s), 17.23(s). Appendices 16, 17a and 17b.
4.3 Imine condensation
All imine condensation reactions were performed under Ar. The oil bath temperature 
varied between 80 and 90 ºC. To be able to clearly see refluxing in the flask, a 
temperature of 85 ºC seemed necessary. Sometimes, the flask lost too much or all of its 
solvent. To stop the solvent from exiting the system, the following procedures should be 
used: Removing the Ar balloon after flushing the system, sealing the system with 
additional Teflon-tape, not lowering the flask deeper into the oil than is necessary and 
using only septa that are still in good condition.
TLC was done to determine the formation of product(s). All products were purified by 
column chromatography. The sample for the column was prepared by mixing the 
reaction mixture with silica gel and evaporating the solvent.  Between 22 and 30 cm of 
silica gel was used for the column. Starting eluent ranged from 1:4 to 1:12 
AcOEt/hexane. More silica and less polar eluent are generally needed for aldehydes 
other than benzaldehyde. The aldehyde came out first and then the product. Eluent 
polarity was increased after some time to get the product out faster but not too much as 
not to push out the boroxazolidone. Product fractions were combined and evaporated. 
4.3.1 3-benzyl-4-isopropyl-2,2-diphenyl-1,3λ4,2λ4-oxazaborol-
5-one (65a)
140 mg (0.5 mmol, 1.0 eq) of boroxazolidone 25, 2 ml of DCE, 0.25 ml (2.5 mmol, 5.0 
eq) of benzaldehyde and 0.15 mmol, (0.3 eq) of Lewis base were mixed in this order 
and kept in a 80 ºC oil bath for 24 h. White/creamy solid (105 mg, 57 % yield, TBD as 
LB); 1H NMR (300 MHz, CDCl3) δ (ppm): 7.42 - 7.48 (m, 4H), 7.30 - 7.37 (m, 6H), 
7.08 - 7.21 (m, 3H), 6.49 (d, J=9 Hz, 2H), 5.00 (s, 2H), 2.99 (quin, J= 6 Hz, 1H), 1.25 
(d, J=9 Hz, 6H). Appendix 18. This spectrum corresponds to Mannoja’s spectrum. 
4.3.2 3-benzylidene-4-isopropyl-2,2-diphenyl-1,3λ4,2λ4-
oxazaborolidin-5-one (65b)
This was done similarly to ketimine 65a. 8.1 mg (0.15 mmol, 0.3 eq) of sodium 
methoxide was used as the LB. Even when the product seemed pure on TLC after 
running column, 1H NMR showed a mixture of aldimine 65b, boroxazolidone 25 and 
benzaldehyde. I.e. the product reverted to its starting materials. White solid (89 mg, 48 
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%, not pure); 1H NMR (300 MHz, CDCl3) δ (ppm): 8.88 (d, J=3 Hz, 1H), 7.70 - 7.85 
(m, 3H), 7.59 - 7.62 (m, 2H), 7.23 - 7.40 (m, 7H), 5.36 (t, J=3 Hz, 1H), 2.12 - 2.25 (m, 
1H), 1.20 (d, J=9 Hz, 3H), 0.66 (d, J=6 Hz, 3H). Appendix 19. This spectrum does not 
entirely match Mannoja’s spectrum of this compound.
4.3.3 3-(4-methoxybenzyl)-4-isopropyl-2,2-diphenyl-1,3λ4,2λ4-
oxazaborol-5-one (67a)
139 mg (0.5 mmol, 1.0 eq) of boroxazolidone 25, 2 ml of DCE, 0.28 ml (2.5 mmol, 5.0 
eq) of 4-methoxybenzaldehyde and 21.0 mg (0.15 mmol, 0.3 eq) of TBD were mixed 
and kept in a 90 ºC oil bath for 24 h. Yellow solid (81 mg, 40 % yield); 1H NMR (300 
MHz, CDCl3) δ (ppm): 7.42 - 7.47 (m, 4H), 7.31 - 7.35 (m, 6H), 6.61 (d, J=9 Hz, 2H), 
6.38 (d, J=9 Hz, 2H), 4.93 (s, 2H), 3.71 (s, 3H), 3.04 (quin, J=7.5 Hz, 1H), 1.24 (d, J=9 
Hz 6H); 13C NMR (75 MHz, CDCl3) δ (ppm): 175.54 (s), 162.89 (s), 159.63 (s), 134.96 
(s), 133.13 (s), 128.87 (s), 128.24 (s), 127.99 (s), 125.89 (s), 114.48 (s), 55.46 (s), 51.65 
(s), 30.15 (s), 17.96 (s). Appendices 20 and 21.
4.3.4 3-(4-bromobenzyl)-4-isopropyl-2,2-diphenyl-1,3λ4,2λ4-
oxazaborol-5-one (67b)
142 mg (0.5 mmol, 1.0 eq) of boroxazolidone 25, 2 ml of DCE, 464 mg (2.5 mmol, 5.0 
eq) of 4-bromobenzaldehyde and 21.0 mg (0.15 mmol, 0.3 eq) of TBD were mixed and 
kept in a 90 ºC oil bath for 24 h. Yellow solid (137 mg, 61 % yield); 1H NMR (300 
MHz, CDCl3) δ (ppm): 7.39 - 7.46 (m, 4H), 7.30 -7.34 (m, 6H), 7.21 - 7.25 (m, 2H), 
6.31 (d, J=9 Hz, 2H), 4.94 (s, 2H), 2.95 (quin, J=6 Hz, 1H), 1.28, d, J=6 Hz, 6H); 13C 
NMR (75 MHz, CDCl3) δ (ppm): 176.01 (s), 162.59 (s), 134.96 (s), 133.05 (s), 132.77 
(s), 132.33 (s), 128.90 (s), 128.35 (s), 128.16 (s), 122.78 (s), 51.36 (s), 30.24 (s), 18.04 
(s). Appendices 22, 23a and 23b.
4.3.5 3-(4-fluorobenzyl)-4-isopropyl-2,2-diphenyl-1,3λ4,2λ4-
oxazaborol-5-one (67c)
140 mg (0.5 mmol, 1.0 eq) of boroxazolidone 25, 2 ml of DCE, 0.27 ml (2.5 mmol, 5.0 
eq) of 4-fluorobenzaldehyde and 21.0 mg (0.15 mmol, 0.3 eq) of TBD were mixed and 
kept in a 90 ºC oil bath for 24 h. White solid (117 mg, 60 % yield); 1H NMR (300 MHz, 
CDCl3) δ (ppm): 7.42 - 7.45 (m, 4H), 7.31 - 7.33 (m, 6H), 6.79 (t, J=9 Hz, 2H), 6.40 - 
6.45 (m, 2H), 4.69 (s, 2H), 2.98 (quin, J=6 Hz, 1H), 1.27 (d, J=6 Hz, 6H); 13C NMR (75 
MHz, CDCl3) δ (ppm): 175.87 (s), 162.67 (s), 162.53 (d, J=247.5 Hz), 134.97 (s), 
133.07 (s), 129.64 (d, J=3.75 Hz), 129.24 (d, J=7.5 Hz), 128.30 (s), 128.10 (s), 116.20 
(d, J=22.5 Hz), 51.29 (s), 30.21 (s), 17.98 (s). Appendices 24, 25a and 25b.
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4.3.6 3-(4-nitrobenzyl)-4-isopropyl-2,2-diphenyl-1,3λ4,2λ4-
oxazaborol-5-one (67e)
142 mg (0.5 mmol, 1.0 eq) of boroxazolidone 25 and 2 ml of DCE were mixed and 
heated in a 90 ºC oil bath. 377 mg (2.5 mmol, 5.0 eq) of 4-nitrobenzaldehyde was 
dissolved in 1 ml of DCE and heated in the oil bath. This was done to make sure that 
both the aldehyde and boroxazolidone are better dissolved before mixing them, in case 
that this has an effect. The aldehyde/DCE solution and 21.0 mg (0.15 mmol, 0.3 eq) of 
TBD were added to the flask and were kept in a 90 ºC oil bath for 24 h. Beige solid (45 
mg, 42 % yield); 1H NMR (300 MHz, CDCl3) δ (ppm): 7.91 - 7.96 (m, 2H), 7.39 - 7.42 
(m, 4H), 7.28 - 7.33 (m, 6H), 6.60 (d, J=9 Hz, 2H), 5.08 (s, 2H), 2.89 (quin, J=9 Hz, 
1H), 1.33 (d, J=6 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ (ppm): 176.56 (s), 162.26 (s), 
147.76 (s), 140.44 (s), 132.99 (s), 130.73 (s), 128.46 (s), 128.35 (s), 127. 92 (s), 124.23 
(s), 51.03 (s), 30.35 (s), 18.15 (s). Appendices 26, 27a and 27b.
4.3.7 3-(4-Trifluoromethylbenzyl)-4-isopropyl-2,2-diphenyl-
1,3λ4,2λ4-oxazaborol-5-one (67f)
142 mg (0.5 mmol, 1.0 eq) of boroxazolidone 25 and 2 ml of DCE were mixed and 
heated in a 90 ºC oil bath for a few minutes to first dissolve the boroxazolidone. After 
the flask had cooled a bit, 0.34 ml (2.5 mmol, 5.0 eq) of 4-trifluoromethylbenzaldehyde 
and 21.0 mg (0.15 mmol, 0.3 eq) of TBD were added. The mixture was kept in a 90 ºC 
oil bath for 24 h. Yellow solid (142 mg, 63 % yield); 1H NMR (300 MHz, CDCl3) δ 
(ppm): 7.39 - 7.45 (m, 4H), 7.37 (s, 1H), 7.30 - 7.34 (m, 7H), 6.57 (d, J=9 Hz, 2H), 5.05 
(s, 2H), 2.92 (quin, J=7.5 Hz, 1H), 1.29 (d, J=9 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ 
(ppm): 176.24 (s), 162.55 (s), 137.61 (s), 137.60 (s), 133.04 (s),  130.77 (quar, J=33 
Hz), 128.38 (s), 128.22 (s), 127.62 (s), 126.05 (quar, J=3.8 Hz), 123.79 (quar, J=271 
Hz), 51.37 (s), 30.25 (s), 18.01 (s). Appendices 28, 29a and 29b.
4.3.8 3-(3-Trifluoromethylbenzyl)-4-isopropyl-2,2-diphenyl-
1,3λ4,2λ4-oxazaborol-5-one (67g)
This was done similarly to 67f. 142 mg (0.5 mmol, 1.0 eq) of boroxazolidone 25, 2 ml 
of DCE, 0.33 ml mg (2.5 mmol, 5.0 eq) of 3-trifluoromethylbenzaldehyde and 21 mg 
(0.15 mmol, 0.3 eq) of TBD were used. White solid (115 mg, 52 % yield); 1H NMR 
(300 MHz, CDCl3) δ (ppm): 7.40 - 7.45 (m, 5H), 7.29 - 7.33 (m, 6H), 7.22 - 7.27 (m, 
1H), 6.68 - 6.73 (m, 2H), 5.06 (s, 2H), 2.93 (quin, J=6 Hz, 1H), 1.30 (d, J=6 Hz, 6H); 
13C NMR (75 MHz, CDCl3) δ (ppm): 176.20 (s), 162.48 (s), 134.62 (s), 132.99 (s), 
131.71 (quar, J=33.7 Hz), 130.47 (s), 129.70 (s), 128.38 (s), 128.24 (s), 125.44 (quar, 
J=3.7 Hz), 123.93 (quar, J=4.0 Hz), 51.31 (s), 30.31 (s), 18.00 (s). Appendices 30, 31a 
and 31b. 
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4.3.9 3-(2-Trifluoromethylbenzyl)-4-isopropyl-2,2-diphenyl-
1,3λ4,2λ4-oxazaborol-5-one (67h)
This was done similarly to 67f. 142 mg (0.5 mmol, 1.0 eq) of boroxazolidone 25, 2 ml 
of DCE, 0.33 ml mg (2.5 mmol, 5.0 eq) of 2-trifluoromethylbenzaldehyde and 20.6 mg 
(0.15 mmol, 0.3 eq) of TBD were used. Yellow solid (18 mg, 8 % yield, 8 mol % 
aldehyde); 1H NMR (300 MHz, CDCl3) δ (ppm): 7.62 (d, J=9 Hz, 1H), 7.40 - 7.44 (m, 
4H), 7.27 - 7.32 (m, 7H), 7.08 (t, J=7.5 Hz, 1H), 5.97 (d, J=9 Hz, 1H), 5.17 (s, 2H), 2.76 
(quin, J=6 Hz, 1H), 1.33 (d, J=6 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ (ppm): 176.74 
(s), 162.35 (s), 132.89 (s), 132.45 (s) 132.44 (s), 131.90 (quar, J=1.5 Hz), 130.74 (s), 
128.49 (s), 128.34 (s), 128.13 (s), 127.25 (s), 126.47 (quar, J=6 Hz), 47.89 (s), 47.85 (s), 
30.10 (s), 17.95 (s). Appendices 32, 33a and 33b.
4.3.10 3-(4-Cyanobenzyl)-4-isopropyl-2,2-diphenyl-1,3λ4,2λ4-
oxazaborol-5-one (67i)
This was done similarly to 67e. 141 mg (0.5 mmol, 1.0 eq) of boroxazolidone 25, 2+1 
ml of DCE, 327 mg (2.5 mmol, 5.0 eq) of 4-cyanobenzaldehyde and 21 mg (0.15 mmol, 
0.3 eq) of TBD were used. Oil T was 85 ºC. Creamy solid (73 mg, 35 % yield); 1H 
NMR (300 MHz, CDCl3) δ (ppm): 7.35 - 7.42 (m, 6H), 7.28 - 7.33 (m, 6H), 6.54 (d, J=9 
Hz, 2H), 5.04 (s, 2H), 2.88 (quin, J=6 Hz, 1H), 1.31 (d, J=6 Hz, 6H); 13C NMR (75 
MHz, CDCl3) δ (ppm): 176.45 (s), 162.31 (s), 138.61 (s), 133.00 (s), 132.80 (s), 130.13 
(s), 128.41 (s), 128.29 (s), 127.72 (s), 118.03 (s), 112.65 (s), 51.27 (s), 30.31 (s), 18.13 
(s). Appendices 34 and 35.
4.3.11 3-(4-Methyl carboxylatebenzyl)-4-isopropyl-2,2-diphenyl-
1,3λ4,2λ4-oxazaborol-5-one (67l)
This was done similarly to 67e. 139 mg (0.5 mmol, 1.0 eq) of boroxazolidone 25, 2+1 
ml of DCE, 410 mg (2.5 mmol, 5.0 eq) of methyl benzaldehyde-4-carboxylate and 22 
mg (0.15 mmol, 0.3 eq) of TBD were used. Oil T was 85 ºC. White solid (95 mg, 43 % 
yield); 1H NMR (300 MHz, CDCl3) δ (ppm): 7.76 (d, J=9 Hz, 2H), 7.42 - 7.47 (m, 4H), 
7.30 - 7.32 (m, 6H), 6.53 (d, J=9 Hz, 2H), 5.04 (s, 2H), 3.87 (s, 3H), 2.92 (quin, J=6 Hz, 
1H), 1.28 (d, J=6 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ (ppm): 176.17 (s), 166.35 (s), 
162.53 (s), 138.52 (s), 134.94 (s), 133.03 (s), 130.40 (s), 130.34 (s), 128.32 (s), 128.16 
(s), 127.14 (s), 52.48 (s), 51.62 (s), 30.26 (s), 18.01 (s). Appendices 36, 37a and 37b.
4.3.12 3-(Benzyl)-4-isopropyl-2,2-bis(4-methylphenyl)-1,3λ4,2λ4-
oxazaborol-5-one (68a)
This was done similarly to 67f. 154 mg (0.5 mmol, 1.0 eq) of 4-methyl-substituted 
boroxazolidone 49a, 2 ml of DCE, 0.25 ml mg (2.5 mmol, 5.0 eq) of benzaldehyde and 
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21 mg (0.15 mmol, 0.3 eq) of TBD were used. Creamy solid (97 mg, 48 % yield); 1H 
NMR (300 MHz, CDCl3) δ (ppm): 7.34 (d, J=6 Hz, 4H), 7.12 - 7.16 (m, 7H), 6.52 (d, 
J=6 Hz, 2H), 4.98 (s, 2H), 2.97 (quin, J=6 Hz, 1H), 2.35 (s, 6H), 1.24 (d, J=6 Hz, 6H); 
13C NMR (75 MHz, CDCl3) δ (ppm): 175.44 (s), 162.86 (s), 137.49 (s), 135.08 (s), 
134.03 (s), 133.13 (s), 129.15 (s), 128.99 (s), 128.51 (s), 127.39 (s), 52.05 (s), 30.16 (s), 
21.51 (s), 17.90 (s). Appendices 38, 39a and 39b.
4.3.13 3-(Benzyl)-4-isopropyl-2,2-bis(3-methylphenyl)-1,3λ4,2λ4-
oxazaborol-5-one (68b)
This was done similarly to 67f. 157 mg (0.5 mmol, 1.0 eq) of 3-methyl-substituted 
boroxazolidone 49b, 2 ml of DCE, 0.25 ml mg (2.5 mmol, 5.0 eq) of benzaldehyde and 
21 mg (0.15 mmol, 0.3 eq) of TBD were used. The temperature was 85 ºC. Creamy 
solid (120 mg, 60 % yield); 1H NMR (300 MHz, CDCl3) δ (ppm): 7.10 - 7.27 (m, 11H), 
6.53 (d, J=6 Hz, 2H), 5.01 (s, 2H), 3.01 (quin, J=6 Hz, 1H), 3.32 (s, 6H), 1.26 (d, J=9 
Hz, 6H); 13C NMR (75 MHz, CDCl3) δ (ppm): 175.57 (s), 162.86 (s), 137.46 (s), 133.91 
(s), 130.02 (s), 129.22 (s), 129.15 (s), 128.71 (s), 128.55 (s), 128.09 (s), 127.39 (s), 
52.12 (s), 30.17 (s), 21.91 (s), 12.97 (s). Appendices 40, 41a and 41b. 
4.3.14 3-(Benzyl)-4-isopropyl-2,2-bis(4-methoxyphenyl)-
1,3λ4,2λ4-oxazaborol-5-one  (68c)
This was done similarly to 67f. 171 mg (0.5 mmol, 1.0 eq) of 4-methoxy-substituted 
boroxazolidone 49c, 2 ml of DCE, 0.25 ml (2.5 mmol, 5.0 eq) of benzaldehyde and 21.5 
mg (0.15 mmol, 0.3 eq) of TBD were used. The temperature was 85 ºC. Creamy solid 
(62 mg, 29 % yield); 1H NMR (300 MHz, CDCl3) δ (ppm): 7.33 - 7.38 (m, 4H), 7.10 - 
7.19 (m, 3H), 6.85 - 6.90 (m, 4H), 6.54 (d, J=6 Hz, 2H), 4.95 (s, 2H), 3.81 (s, 6H), 2.97 
(quin, J=6 Hz, 1H), 1.24 (d, J=9 Hz, 6H); 13C NMR (75 MHz, CDCl3) δ (ppm): 175.27 
(s), 162.82 (s), 159.67 (s), 136.85 (s), 134.37 (s), 133.98 (s), 129.20 (s), 128.54 (s), 
127.32 (s), 113.83 (s), 55.32 (s), 51.94 (s), 31.14 (s), 17.93 (s). Appendices 42, 43a and 
43b. 
4.3.15 3-(Benzyl)-4-isopropyl-2,2-bis(2,4-difluorophenyl)-
1,3λ4,2λ4-oxazaborol-5-one (68d)
175 mg (0.5 mmol, 1.0 eq) of boroxazolidone 49d, 2 ml of DCE, 0.25 ml (2.5 mmol, 
5.0 eq) of benzaldehyde and 21.0 mg (0.15 mmol, 0.3 eq) of TBD were mixed and kept 
in 85 ºC oil bath for 24 h. Creamy solid (115 mg, 52 % yield); 1H NMR (300 MHz, 
CDCl3) δ (ppm): 7.36 - 7.46 (m, 2H), 7.12 - 7.24 (m, 3H), 6.82 - 6.88 (m, 2H), 6.57 - 
6.68 (m, 4H), 5.15 (s, 2H), 3.02 (quin, J=6 Hz, 1H), 1.32 (d, J=9 Hz, 6H); 13C NMR (75 
MHz, CDCl3) δ (ppm): 177.22 (s), 166.55 (dd, J=168.0, 12.8 Hz), 163.30 (dd=174.4, 
12.4 Hz), 162.20 (s), 136.96 - 137.24 (m), 133.57 (s), 129.15 (s), 128.40 (s), 126.35 (s), 
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111.65 (dd, J=19.1, 3.4 Hz), 103.40 (dd, J=30.0, 24.0 Hz), 51.94 - 52.08 (m), 30.00 (s), 
17.54 (s). Appendices 44, 45a, 45b and 45c.
4.4 Additional procedures
4.4.1 Preparation of 4-bromobenzotriflate (70)
The dichloromethane (DCM) used in this reaction was dried by distilling it over 
sodium. 9.45 g (54.7 mmol, 1.0 eq) of 4-bromophenol 69 was mixed with 54 ml of dry 
DCM. 13.5 ml (54.7 mmol, 1.5 eq) of trifluoromethane sulfonic anhydride was mixed 
with 54 ml of dry DCM. 4.5 ml (54.7 mmol, 1.0 eq) of pyridine was added to the 
bromophenol solution while stirring and the mixture was put in a -70 ºC liquid nitrogen 
/ acetone bath. Trifluoromethane sulfonic anhydride solution was slowly added while 
stirring. Solution was allowed to warm to room temperature and stirred for 24 h. 100 ml 
of water and DCM were added. The DCM was separated and washed with 3 x 100 ml of 
water and 100 ml of brine. Dried with sodium sulfate and evaporated. The mixture was 
flushed twice through a column containing 5 cm of silica by using only DCM as the 
eluent to remove impurities. Magnesium sulfate was used to further remove moisture. 
Yellow liquid (15.09 g, 90 % yield); 1H NMR (300 MHz, CDCl3) δ (ppm): 7.54 - 7.63 
(m, 2H), 7.14 - 7.19 (m, 2H); 13C NMR (75 MHz, CDCl3) δ (ppm): 148.69 (s), 133.62 
(s), 123.27 (s), 122.25 (s), 118.91 (quar, J=319 Hz). Appendices 46 and 47.
4.4.2 Preparation of methyl benzaldehyde-4-carboxylate (72)
506 mg (3.66, 1.1 eq) of potassium carbonate was mixed with 12 ml of MeOH. 500 mg 
(3.33 mmol, 1.0 eq) of 4-carboxybenzladehyde 71 and 0.95 ml (9.99 mmol, 3.0 eq) 
dimethyl sulfate were added to the solution while stirring. The solution was stirred at 
room temperature for 3 h. The solution was evaporated; 15 ml of water was added, 
extracted with 3 x 10 ml of ether and dried with sodium sulfate. The mixture was 
purified with column chromatography. 1:4 AcOEt/hexane eluent was used. Beige solid 
(413 mg, 75 % yield); 1H NMR (300 MHz, CDCl3) δ (ppm): 10.10 (s, 1H), 8.18 - 8.21 
(m, 2H), 7.93 - 7.97 (m, 2H), 3.96 (s, 3H). Appendix 48. 1H NMR spectrum matches to 
the one of the same compound on Sigma-Aldrich’s website [58].
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5. CONCLUSIONS
Five different TEATABs were successfully prepared with yields ranging from 13 to 95 
%. The TEATABs were substituted with hydrogen, 4-methoxy, 4-methyl, 3-methyl and 
2,4-difluoro groups. The best yield of 95 % was achieved with the non-substituted 
TEATAB, but it was made from commercial sodium tetraphenylborate, and the others 
were made via Grignard reactions by using different aryl bromides. The yield from this 
reaction depends highly on the solubility difference of the NaTAB and TEATAB in a 
water/methanol solvent system. Attempts to produce 4-nitrile and 4-triflate-substituted 
TEATABs were unsuccessful. The Grignard reaction for 4-bromobenzonitrile failed, 
and the 4-triflate-substituted TEATAB reaction seemed to produce a mixture of 
triarylborate and tetra-arylborate.
Five different boroxazolidones were successfully prepared from the TEATABs and (L)-
valine with yields varying from 95 to 47 %. The best yield was achieved with the non-
substituted TEATAB and the lowest with 4-methoxy-substituted TEATAB. The yield 
from this reaction is highly dependent on the low solubility of the boroxazolidone to the 
reaction solvent. The 2,4-difluoro-substituted boroxazolidone had to be purified by 
column chromatography because of its high solubility to the reaction solvent, after 
which a good yield was achieved.
The imine condensation reaction of non-substituted boroxazolidone and benzaldehyde, 
already improved by Mannoja, was further studied with different Lewis bases. The yield 
of 62 % for the ketimine reported in her thesis could not be replicated with any Lewis 
base. The best yield of this ketimine achieved in this study was 57 % with TBD as the 
LB. It was found that NaOMe works better for producing the aldimine than the 
triphenylphosphate PPh3 reported by Mannoja. PPh3 is reported to produce a conversion 
of 13 % of aldimine whereas with NaOMe, a 48 % yield was achieved. However, this 
yield is an estimate because the purity could not be confirmed by 1H NMR. This was 
because the aldimine quickly degraded back to the boroxazolidone and benzaldehyde. 
Mannoja suggested that the formation of either the ketimine or aldimine would depend 
on the catalyzing base either being only a Lewis base in the case of aldimine or being a 
Lewis and Brønsted base in the case of ketimine. The two different pathways presented 
in Scheme 12 for Lewis bases and Brønsted bases to produce an imine would explain 
the route to a ketimine or an aldimine. However, NaOMe and TBD are both Lewis and 
Brønsted bases so the reason behind either a ketimine or an aldimine forming must be 
something else.
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Different aldehydes were tested for producing the ketimine from non-substituted 
boroxazolidone. The best yields were achieved with halogen-substituted benzaldehydes 
with 4-bromo, 4-fluoro and 4-(trifluoromethyl)benzaldehydes having almost equal 
yields of 61, 60 and 63 %, respectively. The yields become lower when using 
benzaldehydes with non-halogenated electron withdrawing substituents, and with the 
exception of 4-methoxybenzaldehyde, no product is formed at all with aldehydes 
containing electron donating substituents. This makes sense when one thinks that 
electron withdrawing substituents make the carbonyl more electrophilic and thus the 
imine formation becomes easier. However, this does not explain why halogen-
substituents have a bigger effect on the yield than electron withdrawing non-halogen 
substituents or why non-substituted benzaldehyde produces a better yield than many 
benzaldehydes with electron withdrawing substituents.
Finally, the four remaining boroxazolidones were tested with benzaldehyde. Yields 
ranged from 60 to 29 % with 3-methyl-substituted boroxazolidone producing the 
highest yield and 4-methoxy-substituted boroxazolidone producing the lowest yield. It 
was hoped that these tests could show if changing the boron’s substituents would affect 
the N-B bond and thus the nitrogen’s nucleophilicity and finally imine formation yield. 
However, there seems to be no clear correlation between electron donating substituents 
on the boron and a higher yield or vice versa. The following order of procedures was 
found to be the best for the imine reactions: adding the boroxazolidone and solvent, 
preheating, cooling, adding the aldehyde, adding the LB and finally setting the mixture 
to barely reflux at 85 °C. Formation of multiple products should always be avoided. 
This is affected by the choice of the LB, temperature, the aldehyde and the 
boroxazolidone.
This investigation produced two clear results. First, the formation of either a ketimine or 
an aldimine does not depend on the catalyst base being only a Lewis base or also a 
Brønsted base because both TBD and NaOMe belong to these two categories. Secondly, 
the imine yield usually increases as the benzaldehyde’s substituents become more 
electron withdrawing. It is difficult to make any other conclusions from this data. More 
boroxazolidones with differing substituents at the boron should be tested to see if a 
correlation between the boron’s substituents and the imine yield could be found. 
Crystallographic measurements would give direct information about the 
boroxazolidones’ and imines’ N-B bonds’ strength. It would be interesting to see how 
the substituents affect the bond strength and how this correlates with the imine yields. 
One practical area of improvement regarding these imines would be the column 
chromatography. The compounds are not very soluble in AcOEt/hexane, which leads to 
using a large amount of solvent for every purification, about 500 - 800 ml. A 
chloroform/hexane eluent system might be more efficient but it was not tested. An 
inherent problem of the reaction chain from an aryl bromide to a TEATAB, to a 
boroxazolidone and finally to the imine, is the low atom economy.
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JRB31_1H.esp
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
9.0112.186.338.138.30
7.
25 7.
24 7.
23
7.
22
7.
21
7.
20
6.
76
6.
73
3.
36
3.
34
3.
31
3.
29
2.
17
1.
36
1.
33
1.
31
54
APPENDIX 4A: 13C NMR FOR COMPOUND 47C
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APPENDIX 4B: 13C NMR CLOSE-UPS FOR COMPOUND 47C
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APPENDIX 5: 1H NMR FOR COMPOUND 47D
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APPENDIX 6A: 13C NMR FOR COMPOUND 47D
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APPENDIX 7: 1H NMR FOR COMPOUND 47E
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APPENDIX 8A: 13C NMR FOR COMPOUND 47E
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APPENDIX 8B: 13C NMR CLOSE-UPS FOR COMPOUND 47E
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APPENDIX 9: 1H NMR FOR COMPOUND 25
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APPENDIX 10: 1H NMR FOR COMPOUND 49A
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APPENDIX 11A: 13C NMR FOR COMPOUND 49A
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APPENDIX 11B: 13C NMR CLOSE-UP FOR COMPOUND 49A
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APPENDIX 12: 1H NMR FOR COMPOUND 49B
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APPENDIX 13A: 13C NMR FOR COMPOUND 49B
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APPENDIX 13B: 13C NMR CLOSE-UP FOR COMPOUND 49B
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APPENDIX 14: 1H NMR FOR COMPOUND 49C
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APPENDIX 15: 13C NMR FOR COMPOUND 49C
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APPENDIX 16: 1H NMR FOR COMPOUND 49D
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APPENDIX 17A: 13C NMR FOR COMPOUND 49D
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APPENDIX 17B: 13C NMR CLOSE-UPS FOR COMPOUND 49D
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APPENDIX 18: 1H NMR FOR COMPOUND 65A
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APPENDIX 19: 1H NMR FOR COMPOUND 65B
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APPENDIX 20: 1H NMR FOR COMPOUND 67A
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APPENDIX 21: 13C NMR FOR COMPOUND 67A
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APPENDIX 22: 1H NMR FOR COMPOUND 67B
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APPENDIX 23A: 13C NMR FOR COMPOUND 67B
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APPENDIX 23B: 13C NMR CLOSE-UP FOR COMPOUND 67B
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APPENDIX 24: 1H NMR FOR COMPOUND 67C
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APPENDIX 25A: 13C NMR FOR COMPOUND 67C
JRB91_13C.ESP
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APPENDIX 25B: 13C NMR CLOSE-UPS FOR COMPOUND 67C
JRB91_13C.esp
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APPENDIX 26: 1H NMR FOR COMPOUND 67E
JRB111_1H.ESP
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
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APPENDIX 27A: 13C NMR FOR COMPOUND 67E
JRB111_13C.ESP
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
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APPENDIX 27B: 13C NMR CLOSE-UP FOR COMPOUND 67E
JRB111_13C.esp
135 134 133 132 131 130 129 128 127 126 125 124 123
Chemical Shift (ppm)
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APPENDIX 28: 1H NMR FOR COMPOUND 67F
JRB117_1H.ESP
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
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APPENDIX 29A: 13C NMR FOR COMPOUND 67F
JRB117_13C_2.esp
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
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APPENDIX 29B: 13C NMR CLOSE-UP FOR COMPOUND 67F
JRB117_13C_2.esp
136 134 132 130 128 126 124 122 120 118
Chemical Shift (ppm)
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APPENDIX 30: 1H NMR FOR COMPOUND 67G
JRB133_1H.ESP
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
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APPENDIX 31A: 13C NMR FOR COMPOUND 67G
JRB133_13C.esp
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
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APPENDIX 31B: 13C NMR CLOSE-UP FOR COMPOUND 67G
JRB133_13C.esp
135 134 133 132 131 130 129 128 127 126 125 124 123
Chemical Shift (ppm)
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APPENDIC 32: 1H NMR FOR COMPOUND 67H
JRB121_1H.ESP
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
6.301.002.190.971.206.924.391.40
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APPENDIX 33A: 13C NMR FOR COMPOUND 67H
JRB121_13C_2.esp
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Chemical Shift (ppm)
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APPENDIX 33B: 13C NMR CLOSE-UP FOR COMPOUND 67H
JRB121_13C_2.esp
134.0 133.5 133.0 132.5 132.0 131.5 131.0 130.5 130.0 129.5 129.0 128.5 128.0 127.5 127.0 126.5 126.0 125.5
Chemical Shift (ppm)
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APPENDIX 34: 1H NMR FOR COMPOUND 67I
JRB113_1H.ESP
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
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7.
42
7.
41
7.
40
7.
39
7.
38
7.
31
7.
30
7.
29
7.
29
7.
28
6.
56
6.
53
5.
04
2.
93 2
.9
0 2.
88
2.
86
2.
84
1.
32
1.
30
97
APPENDIX 35: 13C NMR FOR COMPOUND 67I
JRB113_13C.ESP
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
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APPENDIX 36: 1H NMR FOR COMPOUND 67L
JRC25_1H.ESP
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
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APPENDIX 37A: 13C NMR FOR COMPOUND 67L
JRC25_13C.esp
170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
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APPENDIX 37B: 13C NMR CLOSE-UP FOR COMPOUND 67L
JRC25_13C.esp
139 138 137 136 135 134 133 132 131 130 129 128 127 126
Chemical Shift (ppm)
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APPENDIX 38: 1H NMR FOR COMPOUND 68A
JRC13_1H.ESP
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
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APPENDIX 39A: 13C NMR FOR COMPOUND 68A
JRC13_13C.ESP
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
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APPENDIX 39B: 13C NMR CLOSE-UP FOR COMPOUND 68A
JRC13_13C.esp
139 138 137 136 135 134 133 132 131 130 129 128 127 126 125
Chemical Shift (ppm)
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APPENDIX 40: 1H NMR FOR COMPOUND 68B
JRC7_1H.ESP
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
6.526.211.002.071.9411.73
7.
27 7.
26
7.
24
7.
22
7.
22
7.
15
7.
12
7.
11 7.
10
7.
10
6.
54
6.
52
5.
01
3.
05 3.
03 3.
01
2.
98
2.
96
2.
32
1.
28
1.
25
105
APPENDIX 41A: 13C NMR FOR COMPOUND 68B
JRC7_13C.ESP
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
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APPENDIX 41B: 13C NMR CLOSE-UP FOR COMPOUND 68B
JRC7_13C.esp
138 137 136 135 134 133 132 131 130 129 128 127
Chemical Shift (ppm)
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APPENDIX 42: 1H NMR FOR COMPOUND 68C
JRC9B_1H.ESP
7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
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APPENDIX 43A: 13C NMR FOR COMPOUND 68C
JRC9B_13C.ESP
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
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APPENDIX 43B: 13C NMR CLOSE-UP FOR COMPOUND 68C
JRC9B_13C.esp
140 138 136 134 132 130 128 126 124 122 120 118 116 114 112
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APPENDIX 44: 1H NMR FOR COMPOUND 68D
JRC27_1H.ESP
8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
Chemical Shift (ppm)
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APPENDIX 45A: 13C NMR FOR COMPOUND 68D
JRC27_13C.ESP
180 170 160 150 140 130 120 110 100 90 80 70 60 50 40 30 20 10 0
Chemical Shift (ppm)
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APPENDIX 45B: 1ST 13C NMR CLOSE-UP FOR COMPOUND 68D
JRC27_13C.esp
167.5 167.0 166.5 166.0 165.5 165.0 164.5 164.0 163.5 163.0 162.5 162.0
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APPENDIX 45C: 2ND 13C NMR CLOSE-UP FOR COMPOUND 68D
JRC27_13C.esp
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APPENDIX 46: 1H NMR FOR COMPOUND 70
JRC23_1H_2.ESP
8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 0
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APPENDIX 47: 13C NMR FOR COMPOUND 70
JRC17_13C_2.ESP
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APPENDIX 48: 1H NMR FOR COMPOUND 72
JRC19_1H.ESP
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